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SEEING 
They took away what should have been my eyes, 
(But I remembered Milton's Paradise) 
They took away what should have been my ears, 
(Beethoven came and wiped away my tears) 
They took away what should ha:ve been my tongue, 
(But I had talked with God when I was young) 
He would not let them take a way my soul, 
Possessing that, I still possess the whole. 
Helen Keller 
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The inherited retinal degenerative disorders are a common cause of severe visual 
handicap in the W estem world. Retinitis pigmentosa (RP) is a group of retinopathies in 
which a primary feature is a progressive loss of photoreceptor and retinal pigment 
epithelium function. Over the last decade, investigations into the patho-physiology of RP 
have identified numerous disease-causing genes and loci (for a current listing refer to the 
web site http://www.sph.uth.tmc.edu/Retnet/). 
A study of a South African family with an autosomal dominant form of RP (adRP) forms 
the basis of this dissertation. In this family, comprising 44 individuals, the first 
manifestation of visual disturbance is usually evident between 20 and 30 years of age. 
Subsequently, another South African adRP family, consisting of25 members, 1was also 
incorporated into this investigation. 
Genetic linkage analysis facilitated the mapping of the disease phenotype in the two South 
African adRP families to a 10 cM interval on chromosome 17 q22. This novel locus, 
designated RPI 7, is the eighth identified for adRP. Haplotype construction in the two 
' 
kindreds, in conjunction with multipoint analyses subsequently fine mapped RPI 7 to a 
1 cM region between microsatellite markers D 17S 1604 and D 17S948. Although the two 
families are from ethnically diverse population groups, they share the same disease-
associated haplotype spanning 12 cM, which suggests that the disorder may be caused by 
the same pathogenic mutation in the same gene. 
The positional cloning approach was utilised in an endeavour to identify the RPI 7 gene 
and an attempt was made to construct a physical map of the 1 cM critical region. A contig 
consisting of seven yeast artificial chromosome (Y AC) clones was assembled using 
sequence-tagged-site (STS) content mapping. In order to close a gap in the Y AC contig, a 
bacterial artificial chromosome (BAC) library was screened and the vectorette PCR 
technique was used to verify overlapping sequences. 
This contig should provide a useful tool for the purpose of isolating genes or transcription 
units within the RPI 7 critical interval. In this regard, purified Y AC DNA was isolated 
IX 
using pulsed-field gel electrophoresis and the cDNA selection technique was employed to 
generate a transcription map. This approach was applied to YAC 75Ic12 using a foetal 
brain cDNA library, and two rounds of selection were performed to create a sub-library 
for enriched cDNAs derived from this clone. Screening for the presence of contaminating 
sequences in the 480 transformants revealed that (i) approximately 7% of the selected 
clones contain COT-I DNA and (ii) none of the clones were contaminated with yeast 
ABI380 DNA. Ten randomly chosen clones were sequenced and subjected to BLASTN 
analysis, which revealed the presence of a 23 bp contaminant, known genes as well as 
novel transcripts. 
In order to optimise efforts to isolate the adRP gene, four positional candidates residing 
on I 7q were screened for evidence implicating them in the adRP phenotype in the two 
I 7q22-linked families. The genes investigated were: PDEG (gamma subunit of rod 
phosphodiesterase), TIMP2 (tissue inhibitor of metalloproteinases-2), PKCA (protein 
kinase C alpha) and retinal fascin. These candidates were chosen on the basis of (i) 
mapping to I 7q, (ii) expression in the retina and/or (iii) potential involvement in the rod 
phototransduction pathway. Recombination events between the adRP locus and a single 
strand conformation polymorphism (SSCP) in PDEG, and a restriction fragment length 
polymorphism (RFLP) in TIMP2 provided evidence for the exclusion of these candidate 
genes. A novel SSCP detected in the promoter region of retinal fascin was genotyped in 
the two adRP families and showed a lack of co-segregation with the disease locus. 
Furthermore, direct DNA sequencing of the coding regions as well as the promoter region 
of retinal fascin in RP affected family members did not reveal any pathogenic mutations. 
In addition, data is provided which suggests that PKCA does not reside on any of the 
YACs and BACs encompassing the RPI 7 critical interval. This gene is therefore unlikely 
to be responsible for the adRP phenotype in the two RPI 7-linked families. 
Ultimately, the work reported in this thesis may contribute to the body of knowledge on 
inherited retinal degenerative disorders. Moreover, this investigation should provide the 
basis for further study of the aetiology of RP in all families linked to the RPI 7 locus on 
chromosome I 7q22. The immediate application of these molecular findings is the 
potential for pre-symptomatic testing of at-risk members from the two adRP kindreds. 
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PLAN OF THESIS 
This dissertation is divided into six chapters and the layout is as follows: 
Chapter One provides a background to hereditary retinal degenerative disorders, 
focussing on retinitis pigmentosa (RP). Chapter Two is a synopsis of the 
development of research on RP in South Africa, and includes an outline of the aim 
of the study and the experimental approach to the investigation. 
Chapters T~ee, Four and Five are the experimental chapters, each dealing with a 
/ 
different aspect of the molecular genetic investigation that forms the basis of this 
study. Each of these chapters is divided into four sections i.e. Introduction, 
Materials & Methods, Results and Discussion. Chapte~ Three describes the 
intensive genetic linkage study undertaken in a large South African family in order 
to map a gene underlying an autosomal dominant form of RP. Chapter Four 
deals with the construction of a physical map for the locus mapped in Chapter 
Three. In addition, this chapter describes the approach used towards generation of 
a transcription map for this region. The screening of positional candidate genes for 
RP 17 is discussed in Chapter Five. 
The conclusions drawn for each aspect of this study are discussed in detail at the 
end of the relevant Chapter. Chapter Six provides a final comment on each of 
these facets and includes future research prospects, which are recommended based 




1.1 THE BIOLOGY OF VISION 
1.1.1 Structure of the eye 
1.1.2 Retina 
1.1.3 Rod phototransduction cascade 
1.2 HEREDITARY RETINAL DYSTROPHIES 
1.3 RETINITIS PIGMENTOSA (RP) 
1. 3. 1 Clinical aspects of RP 
1.3.1.1 Delineation of the disorder 
1.3.1.2 Manifestations of RP 
1.3.2 Genetics of RP 
1.4 AUTOSOMAL DOMINANT RP (adRP) 
1.4.1 Molecular background 
1.4.2 rhodopsin gene (RP4 locus) 




1.1 THE BIOLOGY OF VISION 
1.1.1 Structure of the eye 
3 
The human eye is a small yet complex organ, composed of three main 
layers (Fig. l. l)[James et al. 1997] 
(i) The tough outer corneo-sclera layer forms the transparent 
cornea anteriorly, and also provides sites for the attachment 
of ocular muscles and gives the eye its mechanical strength. 
I 
(ii) The uvea, the middle vascular layer, consists of the iris and 
ciliary body_anteriorly which extend posteriorly into the 
choroid, a pigmented layer carrying a rich supply of blood 
vessels. 
(iii) The retina is the innermost layer and it consists of two main 
components, the retinal pigment epithelium (RPE) and the 
multi-layered neural retina. 
Bruch's membrane, an extracellular matrix composed of structural 
proteins, is situated between the RPE and the choroid. 
1.1.2 Retina 
The retina arises as an evaginated portion of the mid brain (the optic 
vesicle), which subsequently invaginates to form the two-layered optic 
cup (Freund et al. 1996). The outer layer of the optic cup evolves into the 
RPE and the inner layer forms the neural retinal tissue, which later 
differentiates into photoreceptor cells, intermediate neurons, ganglion 
cells and various supporting cells (Fig. 1.2). The cells in the mature 
retina do not divide. Photoreceptor cells are light sensitive and are 
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Bruch's membrane 
choroid 
Figure 1.2 Schematic representation of the layers in the retina. 
(Reproduced and modified from BioLone1M, Germany) 
photons of light and pass these in the form of electrical impulses to the 
intermediate neurons, where electrical processing takes place. The 
impulse is then transmitted to the ganglion cells, which have long fibres 
collectively forming the optic nerve. This nerve forms the pathway of 
visual information from the eye to the brain. 
The two main morphological types of light-sensitive photoreceptor cells, 
the rods and the cones (Fig. 1.3) share many metabolites and cofactors 
but differ in their anatomical distribution within the retina. The biology 
of the photoreceptor cells is well-documented (Yau 1994) and an outline 
of their structure and function is given below: 
There are approximately 6 million cone photoreceptor cells (Fig. 1.3a) in 
each eye and the macula lutea, the central region of the retina at which 
visual perception is most acute, is cone-rich. These photoreceptor cells 
are responsible for colour vision and are important for fine vision. The 
outer segments of cone cells consist of discs (flattened membrane sacs) 
that are continuous with the plasma membrane forming a highly 
convoluted surface membrane. 
Rod cells (Fig. 1.3b), numbering about 120 million in each eye, are 
distributed throughout the retina, with the exception of the centre of the 
fovea. These cells are responsible for dim light vision, peripheral vision 
and contrast sensitivity. The outer segments of rod cells consist of a 
stack of discs separated by thin layers of cytoplasm and surrounded by 
the plasma membrane. Old discs are phagocytosed by the RPE and new 
discs are constantly resynthesised. The disc and plasma membranes 
form the site of the rod phototransduction pathway, which is discussed 
in the following section. 
6 
free-floating discs 











Figure 1.3 The two types of photoreceptor cells. 
(a) cone cell (b) rod cell 






1.1.3 Rod phototransduction cascade 
Sight depends fundamentally upon the detection of light and its 
conversion by synaptic responses into a form interpretable by the 
neurons. This biological process, termed the phototransduction cascade 
(Stryer 1991) takes place in the outer segments of the rod (Fig. 1.4) and 
cone cells. The pathway begins with a visual image entering the eye in 
the form of photons of different wavelengths of light, which strike the 
photoreceptor layer. 
In dim light vision, rhodopsin, the visual pigment in rod cells, absorbs 
the photons, thereby inducing the isomerisation of the associated retinal 
chromophore from the 11-cis to the all-trans form. In turn, photoexcited 
rhodopsin, termed metarhodopsin II, activates transducin, which is a 
trimeric G protein composed of alpha, beta and gamma subunits. 
Activated transducin exchanges its bound GDP for GTP on the alpha 
subunit and dissociates from the beta and gamma subunits . The third 
component of the phototransduction cascade is the enzyme 
phosphodiesterase (PDE) which comprises catalytic alpha and beta 
subunits and two inhibitory gamma subunits. The alpha subunit of 
transducin binds to the gamma subunits of PDE thereby releasing their 
inhibitory constraint. Activated PDE immediately hydrolyses many 
molecules of cGMP, the nucleotide responsible for maintaining open 
cGMP-gated cation channels in the dark. The closure of the channels 
results in a decrease in the free Ca2+ concentration in the outer segment 
because Ca2 + can no longer enter the cell but continues to exit through 
h + 2+ + t e Na -Ca -K exchanger. 
This process generates a transient electrical hyper-polarisation of the 
plasma membrane, which produces a neural signal. Rod cells usually 















Figure 1.4 Scheme representing the rod phototransduction pathway. Incident light (photon) 
photo-activates rhodopsin, and initiates a cascade of reactions involving transducin 
and PDE. This pathway produces a relative decrease in intracellular cGMP leading 
to closure of the sodium channels which generates the visual signal. 
GDP = guanosine diphsphate; GTP = guanosine triphosphate; 
PDE = phosphodiesterase; cGMP = cyclic guanosine 3 ' ,5 ' -monophosphate. 
(Reproduced from Lolley 1994 ). 
10 
distribution of positive and negative charges inside and outside the 
plasma membrane. When the channels close, however, the membranes 
become more negative, about -70 mV, and this gives rise to a brief 
voltage pulse. Further processing of the neural signal occurs in the inner 
retinal layers and in specialised regions of the brain. After activation, 
several different mechanisms are responsible for restoring the cell to the 
resting (dark) state. Photoexcited rhodopsin is deactivated through 
phosphorylation by rhodopsin kinase and subsequent binding of 
arrestin. A similar phototransduction cascade has been proposed for 
cone photoreceptors, with different visual pigments in each of the three 
(red, blue and green) cone cell types. 
1.2 HEREDITARY RETINAL DYSTROPHIES 
Over the last decade, molecular genetics and molecular biology 
techniques have identified the genetic defects underlying numerous 
hereditary eye disorders. This knowledge has enabled an improved 
classification of these disorders, which could not have beert elucidated 
using clinical classification schemes alone. 
This dissertation deals with a subgroup of genetic eye conditions in 
which mainly the retinal tissue is affected. In this regard, a selected list 
of photoreceptor and retinal pigment epithelium dystrophies, which have 
been mapped, is presented in Table 1.1. Only a small proportion of the 
inherited retinal dystrophies is listed since a complete categorisation is 
beyond the scope of this dissertation. A comprehensive list is, however, 
available on the World Wide Web at the site 
http:/ /www.sph.uth.tmc.edu/Retnet/. 
























Stargardt macular dystrophy 
arRP 
Usher syndrome type II 
Choroideremia-like dystrophy 
Bardet-Biedl syndrome type III 
adRP 
arRP 
Stationary night blindness 
Usher syndrome type III 
arRP 




Vitelliform macular dystrophy 
DigenicRP 
Pattern macular dystrophy 




Martinez-Mir et al. 1997 
Allikmets et al. 1997 
van Soest et al. 1994 
Eudy et al. 1998 
van Bokhoven et al. 1994 
Sheffield et al. 1994 
Dryja et al. 1990 
Rosenfeld et al. 1992 
Dryja et al. 1993 
Sankila et al. 1995 
McLaughlin et al. 1993 
Gal et al. 1994 
Dryja et al. 1995 
Huang et al. 1995 
Farrar et al. 1991 
Wells et al. 1993 
Kajiwara et al. 1994 
Weleber et al. 1993 
Kajiwara et al. 1993 
W eleber et al. 1993 
N akazawa et al. 1996 





Knowles et al. 1994 
Stone et al. 1994 
Table 1.1 - continued 12 
CHROMOSOME DISORDER REFERENCE 
(GENE). 
6q16 North Carolina macular dystrophy Small et al. 1992 
6q25-26 Cone dystrophy Milosevic et al. 1975 
7p15-21 Cystoid macular dystrophy Kremer et al. 1994 
7p15-13 adRP Ingleheam et al. 1993 
7q31-35 adRP Jordan et al. 1993 
8ql 1-21 adRP Blanton et al. 1991 
8q24 Atypical vitelliform dystrophy Ferrel et al. 1983 
lOp (PAHX) Refsum disease Mihalik et al. 1997 
10q26 (OAT) Gyrate atrophy Dietz et al. 1993 
lOq Usher syndrome type ID Wayne et al. 1996 
llp15 Usher syndrome type IC Keats et al. 1994 
llql3 Exudative vitreoretinopathy Li et al. 1992 
llql3 (bestrophin) Best macular dystrophy Petrukhin et al. 1998 
llql3 (myosin VIIA) Usher syndrome type IB Weil et al. 1995 
llql3 Inflammatory vitreoretinopathy Stone et al. 1992 
1 lql3 Bardet-Biedl syndrome type I Leppert et al. 1994 
1 lql3 (ROMl) Digenic RP Kajiwara et al. 1994 
1 lq14-21 (TYR) Oculocutaneous albinism Oetting et al. 1993 
13q34 Stargardt macular dystrophy Zhang et al. 1994 
13q14 (Rb) Retinoblastoma Sippel et al. 1998 
14q32 Usher syndrome type IA Kaplan et al. 1992b 
15qll-12 (P) Oculocutaneous albinism Lee et al. 1994 
15q22-23 Bardet-Biedl syndrome type IV Carmi et al. 1995 
16q13-22 Bardet-Biedl syndrome type II Kwitek-Black et al. 1993 
17p13.3 adRP Greenberg et al. 1994a 
17p (GUC2D) Leber's congenital amaurosis Perrault et al. 1996 
Table I. I- continued 13 
CHROMOSOME DISORDER REFERENCE 
(GENE) 
17qll Cone rod dystrophy Kylstra et al. 1993 
17q22 adRP Bardien et al. 1995 
18q21 Cone rod dystrophy Warburg et al. 1991 
19q13 Cone rod dystrophy Evans et al. 1994 
19q adRP Al-Maghtheh et al. 1994 
21q21 Usher syndrome type IE Chaib et al. 1997 
· 22q13-qter (TIMP3) Sorsby fundus dystrophy Weber et al. 1994 
Xp22 (OAl) Ocular albinism Bassi et al. 1995 
Xp22.2 (XLRS 1) · Juvenile retinoschisis Sauer et al. 1997 
Xp2 l. l (RPGR) X-linked RP (RP3) Meindl et al. 1996 
Xp21 Aland Island eye disease Pillers et al. 1990 
Xp21 X-linked RP (RP6) Ott et al. 1990 
Xpl 1.4 Cone-rod dystrophy Seymour et al. 1998 
Xp 11.4 (NDP) Norrie disease Meindl et al. 1992 
Xpll Stationary night blindness Bech-Hansen et al. 1998 
Xpll Exudative vitreoretinopathy Chen et al. 1993 
Xpl 1.3 (RP2) X-linked RP (RP2) Schwalm et al. 1998 
Xpll.3 Stationary night blindness Musarella et al. 1989 
Xpll.2 Incontinentia pigmenti Hodgson et al. 1985 
Xq22 (REPl) Choroideremia Cremers et al. 1990 
Xq26-27 Albinism-deafness syndrome Shiloh et al. 1990 
Xq27-28 Incontinentia pigmenti Sefiani et al. 1989 
Xq28 (red cone opsin) Cone dystrophy Bergen et al. 1997 
Mitochondria Kearns-Sayre syndrome Moraes et al. 1989 
Mitochondria Leber' s ootic atrophy Wallace et al. 1988 
Where known, the causative gene is given in parenthesis after the chromosomal location. 
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The hereditary retinal dystrophies are very heterogeneous. The 
information provided with each disorder in Table 1.1 exemplifies the high 
level of: 
• Genetic or locus heterogeneity (different genes resulting in the 
same disorder, e.g. nine loci for autosomal dominant retinitis 
pigmentosa (adRP); three loci for X-linked RP (xlRP); four for 
Bardet-Biedl syndrome) 
• Allelic heterogeneity (different mutations in the same gene 
causing either the same disorder or distinct conditiop.s, e.g. 
different mutations in rhodopsin responsible for autosomal 
recessive RP (arRP), adRP and congenital stationary night 
blindness) 
• Clinical heterogeneity (the same mutation causing different 
manifestations in affected individuals, even within the same 
family, e.g. a specific mutation in peripherin/RDS causing 
either RP, pattern macular dystrophy or fundus 
flavimaculatus). 
The clinical features of a few of the well-characterised inherited 
retinopathies listed in Table 1.1 (with the exception of retinitis 
pigmentosa which is discussed in Section 1.3) are summarised in Table 
1.2. 
Table 1.2 Clinical phenotype of a selection of the well characterised inherited retinopathies. 
DISORDER. CLINICAL FEATURES 
Macular dystrophies including, A heterogeneous group of disorders with funduscopic changes involving the macula and the RPE. 
- Stargardt macular dystrophy Progressive loss of central vision is a primary feature. 
- Best macular dystrophy 
- Cone-rod dystrophy 
- Butterfly-shaped pattern dystrophy 
- Sorsby fundus dystrophy 
Usher syndrome - Type I RP, congenital severe-to-profound sensorineural deafness and vestibular ataxia. 
Type II RP, congenital moderate-to-severe hearing impairment, and normal vestibular function. 
Typeill RP and progressive hearing loss. 
Bardet-Biedl syndrome RP, polydactyly, obesity, kidney disease and mental retardation. 
Stationary night blindness Non-progressive night blindness, reduced visual acuity and myopia. 
Choroideremia Constriction of peripheral vision, reduction of central vision and night blindness. 
Gyrate atrophy Myopia, night blindness, cataracts, and loss of peripheral vision. 
Leber' s congenital amaurosis Early age of onset, greatly impaired vision and extinguished electroretinograms. 
Ocular albinism Albinism of the peripheral and central fundus, decreased visual acuity and nystagmus. 
Aland island eye disease Impaired night and colour vision, myopia and albinism of the central fundus. 
Hereditary juvenile retinoschisis Poor visual acuity and cystic degeneration of the peripheral and central retina. 
Retinitis punctata albescens Retinal pigmentation, arteriolar attenuation, night blindness and constriction of visual fields. 
..... 
VI 
1.3 RETINITIS PIGMENTOSA (RP) 
1.3.1 Clinical aspects of RP 
1.3.1.1 Delineation of the disorder 
In 1882, J Hutchinson wrote: 
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"Many years ago a well dressed man who looked in excellent health, came 
to my desk in the outpatient room, at Moor.fields, and in a somewhat 
excited manner declared 'I am going blind Sir! you can do nothing for me I 
know! It is in the family, and has been for centuries, and at the present 
time I know more than thirty who are either blind or on the way to it. When 
once it begins it always goes on; still I should be glad if you would look at 
my eyes.' I did so and found, as I expected, that he was the subject of 
retinitis pigmentosa. " 
Retinitis pigmentosa (RP) is a generic n?-me for a group of hereditary 
retinal dystrophies characterised by progressive, symmetrical and 
bilateral degeneration of retinal tissue. It is a common cause of severe 
visual handicap and complete blindness may develop in the later stages. 
The prevalence of RP in Europe and the USA has been estimated to range 
from 1 in 3000 to 1 in 7000 (Humphries et al. 1990). 
The term 'retinitis' implies an inflammatory disease of the retina and 
'pigmentosa' refers to the characteristic appearance of abnormal clumps 
of black, spicular pigment which are present in the retina of affected 
persons. Since the RP group of conditions refers to hereditary retinal 
dystrophies and not inflammatory diseases, the 'itis' part of the name is 
unjustified. Also, it is now known that the presence of the pigmentary 
patches is a consequence of RP and not its cause. Histological analysis 
has revealed that the black pigmentation is due to an invasion of the 
degenerating neural retina by melanin-pigmented cells of the RPE layer 
(Bird 1975). Many names have been suggested for this group of 
disorders, but the misleading term 'retinitis pigmentosa', first coined by 
Donders (1857), is still used. 
1.3.1.2 Manifestations of RP 
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The clinical features of RP are well documented and vary amongst 
affected persons (Kanski 1994). One of the earliest manifestations is 
night blindness, also referred to as 'nyctalopia'; another common feature 
is poor contrast sensitivity. As the peripheral cone photoreceptor cells 
gradually degenerate, there is a concomitant loss of peripheral vision and 
eventually, affected persons experience 'funnel vision', retaining only the 
central portion of their visual fields. In advanced stages of the disorder, 
poor central vision and an inability to distinguish colours may ensue, 
usually culminating in severe visual impairment or blindness. A RP 
fundus (i.e. inside of the eyeball as viewed through an ophthalmoscope) 
usually exhibits three striking features: (i) attenuation of the retinal 
blood vessels, (ii) intraretinal spicular pigmentation and (iii) waxy pallor 
of the optic disc. In affected persons, progressive deterioration of retinal 
function may be demonstrated by electroretinography (ERG), in which 
the electrical signals generated by the retina in response to flashes of 
light are reduced in amplitude and delayed in response times (Berson 
1993). 
1.3.2 Genetics of RP 
The monogenic forms of RP can be inherited as autosomal dominant 
(adRP), autosomal recessive (arRP), X-linked recessive (xlRP), X-linked 
dominant and syndromic forms (Rosenfeld et al. 1994). There has also 
been a report of digenic RP in which mutations in two genes, 
peripherin/ RDS and ROM], are necessary for manifestation of the disease 
phenotype (Kajiwara et al. 1994). Affected persons without a positive 
family history are designated as having 'sporadic' or 'simplex' RP. In 
general, the age of onset, rate of progression, extent of eventual visual 
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loss, and the presence or absence of associated ocular features are 
related to the mode of inheritance of RP. The X-linked recessive form of 
the disorder usually runs the most severe course and the af~ected person 
often has significant visual handicap by the fourth decade (Kanski 1994). 
The prevalence of the various genetic forms of RP varies considerably 
from country to country (Jay 1982; Greenberg et al. 1993). This situation 
reflects ethnic and socio-demographic factors (i.e. founder effects, 
consanguinity etc.) which influence the frequency of any genetically 
determined disease in a given population. 
1.4 AUTOSOMAL DOMINANT RP (adRP) 
This dissertation is focused upon the autosomal dominant forms of RP, 
which were originally subdivided into three broad categories (Lyness et 
al. 1985): 
(i) Type 1 or D-type presents with diffuse and severe loss of rod 
function early in life but cone function is preserved until much later. 
This form of the disorder is also characterised by an early age of onset 
and rapid progression. 
(ii) Type 2 or R-type results in simultaneous regional or patchy loss of 
both rod and cone function. This type has a slower progression and a 
variable age of onset. 
(iii) Sectorial or sector RP is rare and consistently involves only one 
quadrant of the eye. 
1.4.1 Molecular background 
In autosomal dominant disorders there is direct parent-to-child 
transmission of the condition and each offspring of an affected parent, 
regardless of the sex of the parent or child, is at 50% risk of inheriting 
the condition. In this mode of inheritance, the abnormality is expressed 
in the heterozygous state. 
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An understanding of the aetiology of RP has improved dramatically over 
the past decade with the discovery of several of the causative genes. In 
adRP, mutations in two genes viz. rhodopsin (Dryja et al. 1990) and 
peripherin/ RDS (Farrar et al. 1991; Kajiwara et al. 1991) have been 
associated with the condition. The disorder may be the result of either a 
dominant negative effect i.e. where the product of the abnormal gene 
interferes with cell function, or through the shortage of product from the 
normal gene (haploinsufficiency) (Strachan and Read 1996). The 
dominant negative effect was elucidated following the observation that 
mice transfected with a mutant rhodopsin gene develop retinal 
degeneration, despite having the usual complement of normal genes 
(Olsson et al. 1992). The second possibility of haploinsufficiency was first 
demonstrated in the rds mouse, in which transgenic rescue was achieved 
by insertion of a normal peripherinlrds gene (Travis et al. 1992). 
During the last decade an additional seven anonymous adRP loci have 
been mapped to chromosomes: 
(i) 8q (RPl locus, Blanton et al. 1991), 
(ii) 7p (RP9 locus, Inglehearn et al. 1993), 
(iii) 7q (RPlO locus, Jordan et al. 1993), 
(iv) 19q (RPl 1 locus, Al-Maghtheh et al. 1994), 
(v) 17p (RP13 locus, Greenberg et al. 1994a), 
(vi) 17q (RP17 locus, Bardien et al. 1995) 
(vii) lq (RP18 locus, Xu et al. 1996). 
Positional cloning approaches have been embarked upon in attempts to 
isolate the above disease-causing genes, but by the end of 1998 none 
had been identified (Inglehearn 1998). The numerical designation for 
each locus (e.g. RPlO, RPl 7), used by McKusick in the catalogue 
'Mendelian Inheritance in Man' (McKusick 1994) and the online version 
(OMIM, http:/ /www.ncbi.nlm.nih.gov/Omim/) is significant only for 
classification purposes and does not correlate with the chronological 
order of gene identification or phenotypical characteristics. 
1.4.2 rhodopsin gene (RP4 locus) 
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The first gene shown to be causative of adRP was identified through a 
combination of forward and reverse genetics. The Humphries group in 
Dublin initially established linkage of an adRP gene to chromosome 3q 
(McWilliam et al. 1989). Later, Dryja and co-workers in Boston, who were 
pursuing a candidate gene approach, investigated the rhodopsin gene 
which they knew mapped to this region and found a mutation which was 
associated with the disorder in a group of RP patients (Dryja et al. 1990). 
To date, over 100 mutations in rhodopsin have been shown to be 
associated with RP and other forms of retinal degeneration. A 
comprehensive rhodopsin mutation database is available at the World 
Wide Web site at http:/ /mol.ophth.uiowa.edu/MOL_WWW /Rhotab.html. 
Rhodopsin is the visual pigment, which mediates dim light vision in the 
rod phototransduction cascade (Section 1.1.3). This molecule is formed 
by a complex of opsin (a protein consisting of seven transmembrane 
helices) and 11-cis-retinal (a Vitamin A-derived chromophore). Opsin and 
the chromophore are linked covalently via a Schiff base bond. In 1958, 
the photoisomerisation of retinal from 11-cis to the all-trans form was 
identified as the initiating event in the rod visual excitation cascade 
(Hubbard and Kropf 1958). The product of rhodopsin is 348 amino acids 
in length and it is a member of the ancient superfamily of G-protein 
coupled receptors. Rhodopsin is rod cell-specific and it is located 
exclusively in the disc and plasma membranes of rod outer segments 
(Fig. 1.3), where it constitutes approximately 90% of the protein 
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component. A human rod contains approximately 5 X 107 rhodopsin 
molecules, which are synthesised throughout life at a rate of 5 X 106 
molecules/rod/ day (Knowles and Dartnall 1977). This protein is 
produced in rod inner segments and post-translationally modified by the 
addition of oligosaccharides and fatty acids. It is then assembled into 
vesicles, transported to the connecting cilium and inserted into nascent 
discs. 
1.4.3 peripherin/RDS gene fRP7 locus) 
The second gene identified for adRP is peripherin/ RDS (Farrar et al. 
1991; Kajiwara et al. 1991). A mutation in this gene was first found to be 
responsible for retinal degeneration in the mouse and resulted in the 
phenotype, 'retinal degeneration slow' (Van Nie et al. 1978). The 
subsequent investigation of the human homologue has revealed that 
mutations within the gene are associated with a variety of clinically 
distinct retinal degenerations, including retinitis pigmentosa, adult 
vitelliform macular dystrophy (Wells et al. 1993), pattern macular 
dystrophy (Weleber et al. 1993), fundus flavimaculatus (Weleber et al. 
1993), butterfly-shaped pigment dystrophy of the fovea (Nichols et al. 
1993) and retinitis punctata albescens (Kajiwara et al. 1993). The 
comprehensive and current peripherin/ RDS mutation database can be 
accessed at the World Wide Web site: 
http:/ /mol.ophth.uiowa.edu/MOL_WWW /RDStab.html. 
The protein product of peripherin/ RDS is a 346 amino acid glycoprotein 
consisting of four transmembrane domains. Unlike rhodopsin, 
peripherin/RDS is associated with the outer segment disc membranes of 
both rods and cones. In rods it forms a complex with another membrane-
spanning protein, rod outer segment membrane protein 1 (ROMl). The 
two proteins are structurally similar and share about 35% homology in 
sequence (Bascom et al. 1992a). Currently, the exact function of 
peripherin/RDS is unknown but it is speculated, based on the 
localisation of peripherin/RDS and ROMl to the disc rims, that these 
two proteins may function together as an adhesive complex for the 
stabilisation of the outer segment discs (Bascom et al. 1992a). 
An understanding of the aetiology of retinal dystrophies has improved 
over the last decade with the identification of many of the causative 
genes, but many questions still remain unanswered eg: 
• How does a mutation in the rod-specific proteins, rhodopsin and 
ABCR lead to the degeneration of cone cells? 
• Why does an abnormality of a biochemical pathway not essential for 
cell survival (such as phototransduction) result in cell death? 
• What is the shared pathway that culminates in retinal degeneration 
for different mutations in different genes? 
• What are the genetic and/ or environmental factors affecting clinical 
expression of specific pathogenic mutations. 
These are some of the questions that need to be addressed before a 
complete understanding of the molecular patho-physiology of inherited 
retinal degenerations is possible. 
This dissertation describes an investigation into a form of adRP, which 
will be discussed in detail over the next five chapters. 
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2 
RP RESEARCH IN SOUTH AFRICA 
Summary: 
Chapter two discusses the development of research on RP 
in South Africa. An introduction is provided to the present 
study, which is based on the investigation of an adRP gene 
in a South African kindred. In this study, the experimental 
approach used included genetic linkage analysis, physical 
mapping and positional candidate gene screening. An 
outline to these approaches is discussed at the end of the 
chapter. 
2.1 INTRODUCTORY BACKGROUND 
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Research into RP in South Africa (SA) was initiated in 1972 in the 
Department of Human Genetics, University of Cape Town (UCT) 
[hereafter referred to as the Department]. The Department, in 
collaboration with the Department of Ophthalmology at Groote Schuur 
Hospital in Cape Town, documented and maintained records concerning 
South African RP patients and families. In 1985, a questionnaire survey 
was undertaken to determine the relative frequencies of the various 
genetic forms of RP in SA (Oswald et al. 1985). Although preliminary, the 
clinical and genetic data obtained from a total of 130 affected individuals 
in 63 families provided a perspective of the overall situation. The 
proportions of the different genetic subtypes of RP were found to be 14% 
autosomal dominant, 9.5% autosomal recessive and 6% X-linked 
recessive. 
The identification of the first RP gene, rhodopsin (Dryja et al. 1990) 
prompted investigations into the mapping of genes in SA RP families 
(Greenberg et al. 1992; Greenberg et al. 1994b). DNA banking was. 
commenced in 1990 in the molecular genetics laboratory in the 
Department of Human Genetics, with the support from the Retinal 
Preservation Foundation of SA (Greenberg et al. 1993). This laboratory 
now archives patient data and biological material from all forms of 
inherited retinopathies in the SA population, which comprises 
approximately 38 million individuals of different ethnic origins. 
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Approval from the Research Ethics Committee at UCT was obtained prior 
to commencement of this project. With informed consent, genetic nurses 
collect 20 to 30 ml of venous blood from potential research subjects 
throughout the country. The blood specimen, accompanied by a 
completed 'biological specimens collection form' (Appendix A) containing 
the relevant pedigree data, is sent to the molecular genetics laboratory in 
the Department for archiving. As part of the protocol, the blood which is 
drawn in 10 ml aliquots is processed to DNA, as described in Appendix 
B. Arrangements are also made for the affected and at-risk family 
members to have diagnostic ophthalmological investigations at a referral 
centre situated conveniently for the patient. These guidelines are adhered 
to because the collection of accurate clinical details and pedigree data is 
crucial for the mapping of disease-causing genes using genetic linkage 
analysis. 
2.1.1 The current situation 
By May 1999, DNA from 380 families with various hereditary 
retinopathies (including different genetic forms of RP, macular dystrophy, 
Usher syndrome etc.) had been archived. The number of families with the 
different genetic categories, from which DNA is currently stored for 
investigation, is listed in Table 2.1. The term 'sporadic' is used to 
describe a single RP patient with no family history of the disorder and 
the term 'indeterminate' was assigned to those families where, although 
there was more than one affected RP member, the mode of transmission 
27 
could not be deduced from the pedigree. It should be emphasised that, 
due to the Department's research interest in adRP, the incidence of this 
form (16%) presented in Table 2.1 may not be a true reflection of the 
frequency in the population. About a third (30%) of the families from 
which DNA is archived, display some form of macular dystrophy; the 
majority of these kindreds belong to the Afrikaner population group of SA 
and have an autosomal recessive form of Stargardt macular dystrophy. 
Genealogical information suggests that the high incidence of this type of 
inherited retinal degeneration may be due, in part, to a founder effect in 
the Afrikaner population. 
Unpublished data obtained by researchers in the Department suggest 
that the gene pool for RP in SA is likely to vary from that in other parts of 
the world, which may be partly due to the Black African ethnic group in 
this country. This contention is supported by the fact that only 4.5% of 
the families listed in Table 2.1 demonstrate an X-linked mode of 
inheritance, as opposed to the value of 25% reported in the UK (Jay 
1982). Oswald et al. (1985) postulated that a 'reversed founder effect' 
mechanism might be responsible for this difference. Additional evidence 
includes the relative low frequency of rhodopsin mutations in SA families 
when compared with the frequencies reported in overseas studies of 
disease gene demographics, the mapping of two novel SA adRP loci and 
the as yet unmapped loci in other SA adRP families. 
In SA, individuals with retinal degenerative disorders can be divided into 
four different ethnic groups: 
• Black - people of indigenous Black African origin. 
• Mixed ancestry - representing an admixture of San, Khoi-Khoi, West African, 
Madagascan, Javanese and Western European groups. 
• Caucasian - of Western European origin, mainly from Dutch, French, 
German and British stock 
• Asian - of Asian Indian ancestry 
Table 2.la Genetic categorisation of 380 South African families with inherited 
retinopathies from which DNA is archived in the molecular genetics 
laboratory at UCT- May 1999. 
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=rnaBAillE 
adRP 61 16 590 
arRP 48 12 160 
xlRP 17 4.5 69 
Sporadic or Indeterminate 90 24 194 
Usher syndrome 37 10 120 
Macular dystrophies 113 30 291 
Other retinopathies 14 3.5 30 
Table 2.lb Racial breakdown of the 380 South African families. 
adRP 61 7 43 7 1 3 
arRP 48 3 28 0 4 13 
xlRP 17 2 8 1 1 5 
Sporadic 90 19 52 5 0 14 
Usher syndrome 37 4 29 0 3 1 
Macular 113 4 90 7 0 12 
dystrophies 
Other retinopathies 14 0 11 0 0 3 
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2.2 THIS STUDY 
2.2.1 Aim and objectives 
The aim of this study is to investigate the molecular basis of adRP in a 
SA family of Western European descent. This family is one of the largest 
pedigrees from which DNA is archived in the Department, and the 
pedigree structure and adRP phenotype will be discussed in detail in 
Chapter Three. 
The objectives of this study are as follows: 
i) Short term application 
The identification of the disease-causing gene is important, as it will 
allow for pre-symptomatic testing and informed genetic counselling for 
at-risk members from this large family with late-onset adRP; as well as 
other adRP families linked to this gene. 
ii) Long-term application 
The study could lead to an improved understanding of the pathogenic 
pathways or mechanisms causative of adRP and ultimately, an improved 
understanding of the process of vision. In addition, information gleaned 
about the determinant genes is necessary for the development of 
appropriate therapeutic modalities for the affected individuals. 
It is vital to establish which genes are involved in RP in SA as this is a 
highly heterogeneous group of disorders and it is possible that the genes 
detected in local families will be different to those defined in other 
international studies. It therefore follows that gene-specific or mutation-
specific therapeutic modalities developed in other countries may not be 
applicable to SA RP families. 
2.2.2 The experimental approach used 
There are currently two main methods for the identification of defective 
genes underlying hereditary disorders: 
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(i) Genetic linkage analysis and physical mapping (positional cloning 
approach) 
(ii) Positional candidate gene approach. 
2.2.2.1 Genetic linkage analysis 
In linkage analysis, defective genes are located by searching for the co-
inheritance of a specific DNA marker and the disease phenotype. This 
technique is based upon the observation that alleles of two genes or loci 
situated very close to each other on the same chromosome tend to co-
segregate more often than would be expected by chance (Terwilliger and 
Ott 1994). With the discovery of highly polymorphic microsatellite DNA 
markers, an exhaustive investigation of the entire genome is possible 
using this technique. 
2.2.2.2 Physical mapping 
Physical mapping frequently follows genetic linkage analysis as the 
second step towards the identification of the defective gene. Linkage 
studies usually localise the gene to a chromosomal region, which may 
contain several million base pairs and it is therefore necessary to create a 
library of smaller overlapping DNA fragments (a contig), which 
collectively provides complete representation of the region of interest. 
The DNA sequence in each of these fragments could then be assayed for 
gene transcription by a variety of techniques. A search for exon/intron 
boundaries or hypomethylated sites (CpG islands) may indicate the 
presence of a coding sequence. Alternatively, the sequences can be 
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compared to those of known evolutionarily conserved genes in other 
species. Irrelevant genes may be found during this procedure and it is 
necessary to determine which of the potential genes exhibit the tissue 
expression pattern consistent with the disease phenotype, through 
techniques such as Northern hybridisation. Transcripts of these genes 
are more likely to be derived from the mutant gene in question. Finally, it 
is important to identify a mutation in the gene that is present in all the 
affected individuals in the family. The putative pathogenic mutation 
should not be found ins significant sample of the relevant normal 
population in order to rule out a polymorphism. 
While genetic linkage analysis and physical mapping used in concert 
have been successfully employed to clone genes, the latter approach is 
laborious and time consuming. Many factors may hinder the isolation of 
the defective gene from a genetically defined region e.g. the complexity of 
the disease phenotype, the frequency of the disorder in the general 
population and the structure of the gene. The problems in implementing 
this method are highlighted by the fact that it has not been completed 
successfully for any of the adRP genes assigned by linkage thus far. 
Despite the difficulties associated with the positional cloning approach, it 
is inherently valuable because it makes no prior assumptions about the 
genes which are involved. For this reason, this strategy could identify 
genes encoding proteins in novel biochemical pathways that may 
otherwise never be discovered using the candidate gene approach. 
2.2.2.3 Positional candidate gene approach 
This strategy has the potential to reveal the defective gene without 
exhaustive cloning. In this approach, genetic databases and the 
literature are surveyed for previously characterised genes and candidates 
are selected, based on the following guidelines: 
• The biological function of the product of the candidate gene 
should be logically related to the disease process. 
• The candidate should reside in the particular chromosomal 
region to which the defective gene has been mapped. 
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• Markers situated within or close to the gene should exhibit tight 
linkage to the disease phenotype with no recombinations. 
• The candidate gene product should be expressed in the 
appropriate cells and tis.sues related to the disease phenotype. 
Affected persons and their families could then be studied for genetic 
linkage to the candidate gene(s), or the genes could be directly sequenced 
from the affected individual's DNA. Currently, the small number of 
known genes in the candidate chromosomal regions limits this strategy. 
Nevertheless, the Human Genome Project (an international collaboration 
aimed at mapping genes and sequencing the entire human genome) 
should increase the number of mapped genes thereby facilitating this 
approach. 
Both these approaches have been relatively successful in the cloning of 
genes e.g. the dystrophin gene causative of Duchenne muscular 
dystrophy was isolated using positional cloning (Kunkel 1986) and the 
fibrillin gene responsible for Marfan syndrome was identified using the 
candidate gene method (Peltonen and Kainulainen 1992). In the present 
' 
investigation, both strategies were utilised in an attempt to optimise 
efforts to identify the adRP gene. 
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MAPPING OF THE GENE UNDERLYING adRP IN A 
LARGE SOUTH AFRICAN KINDRED 
Summary: 
The adRP phenotype in the family on which this study is 
based is presented in this chapter. Genetic linkage analysis 
was used to map the adRP gene in this kindred to 
chromosome 17q22. Further investigations revealed that 
the disease phenotype in a second SA adRP family was 
linked to the same locus. The construction of haplotypes 
in conjunction with multipoint linkage analyses fine-
mapped the locus to a 1 cM region. This critical interval 
resides between the anonymous microsatellite markers 
Dl 7S948 and Dl 7S1604. 
3.1 INTRODUCTION 
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The assumption that only retina-specific genes would be responsible for 
retina-specific disorders has now been discarded with the discovery of 
some of the causative genes. One example is the product of the TIMP3 
gene, causative of Sorsby fundus dystrophy, which is expressed not only 
in the retina but also in many other tissues and organs (Weber et al. 
1994). The RPGR gene product associated with xlRP is also ubiquitously 
expressed and is found at surprisingly low levels in retina and RPE cDNA 
libraries (Meindl et al. 1996). Another example is the ABCR gene product, 
causative of Stargardt macular dystrophy, which is mainly found in rod 
cells even though the disorder primarily affects cone cells (Allikmets et al. 
1997). These observations indicate that future research efforts into the 
identification of genes causative of inherited retinopathies need to be 
broad-based and with as few assumptions about the patho-physiology as 
possible. 
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Many of the genes causative of genetic disorders have been identified 
with the classical positional approach which involves isolation of the 
gene using only knowledge about its sub-chromosomal location. 
Following the cloning of the gene, further studies can be undertaken to 
determine its function. This process was originally referred to as 'reverse 
genetics' (Ruddle 1984). Usually, the first phase in this strategy is to 
enlist large affected pedigrees with multiple meioses which are then 
examined using genetic linkage analysis. 
3.1.1 Genetic linkage analysis 
This technique facilitates the identification of the chromosomal location 
of a gene without any prior knowledge of its function or any hypothesis 
concerning its role in the pathogenesis of the disorder. In order to map 
the defective gene, a search is undertaken for the co-inheritance of a 
specific genetic marker with the clinical phenotype of the condition 
within a family. 
3.1.1.1 Microsatellite DNA markers 
In the past, human genetic markers included: 
• blood groups (about 20 loci) 
• electrophoretic mobility variants of serum proteins (about 30 loci) 
• human leukocyte antigen (HLA) tissue types (one linked set) 
• DNA restriction fragment length polymorphisms (RFLPs, > 105) 
• DNA mini and microsatellites (> 104) [Strachan and Read 1996]. 
The relatively recent discovery of the highly polymorphic microsatellite 
DNA families (Weber and May 1989) has made genetic linkage analysis 
more powerful and informative than was previously possible with RFLPs. 
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The microsatellite DNA families consist of small arrays of tandem repeats 
which are simple in sequence (usually 1 - 4 bp) and are widely dispersed 
throughout the genome. Of the mononucleotide repeats, runs of A and of 
T are very common. A class of dinucleotide repeats designated (CA)n 
which constitutes one of the most abundant families of human repetitive 
DNA (approximately 50 000 to 100 000 repeats blocks) was identified in 
the 1980s. Uniform spacing of these repeats would place them roughly 
every 30 - 60 kb in the genome. The Alu repeat is the most abundant 
sequence in the human genome, with a copy number of 750 000. The full-length 
Alu repeat is roughly 280 bp long and is usually flanked by short direct repeats. 
The function of microsatellite DNA families is currently unknown, but 
they may play a role in gene regulation or act as hot spots for 
recombination (Slightom et al. 1980; Hamada et al. 1984). The (CA)n 
repeats vary in length among individuals, but are inherited in a 
mendelian manner and can therefore be used as markers in exhaustive 
searches of the entire genome to localise disease-causing genes. 
3.1.1.2 Recombination events 
The basis of linkage analysis is that recombination events occur between 
two genetic loci (a DNA marker and a phenotypic trait) at a rate 
proportional to the distance between them (Terwilliger and Ott 1994). 
Two loci that are situated physically very close to each other tend to be 
co-inherited but as the distance between them increases, the creation of 
new combinations of alleles by recombination becomes more likely. 
Recombination occurs during meiosis when two homologous 
chromosomes line up on the spindle and exchange DNA segments by a 
process termed "crossing over". This event occurs between precisely 
corresponding sequences, so that no base pairs are added to or lost from 
the recombinant chromosome. 
The probability of a recombination event occurring between two loci is 
termed the "recombination fraction" (denoted 8). This expression ranges 
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in value from 0.00 (for loci next to each other) to 0.5 (for unlinked loci 
situated either far apart or on different chromosomes). A genetic map 
distance of 1 centiMorgan (cM) corresponds to a recombination fraction 
of 0.01. At low values of the recombination fraction, the correlation 
between cM and 9 is close. At higher values, however, this agreement is 
no longer valid because double crossovers are more likely to occur at 
larger map distances, thereby negating the effects of the initial crossover 
event. The Haldane or Kosambi map functions may then be used to 
transform the larger recombination fraction values into the equivalent cM 
value (Ott 1991). Haldane takes account of double crossovers but does 
not allow for crossover suppression, Kosambi does both. 
3.1.1.3 Calculation of lod scores 
In linkage analysis a calculation is made of the probability of an 
observed association between the inheritance of a specific DNA marker 
allele and the presence of a phenotypic trait. In essence, a comparison is 
made of the probability that the observed distribution of alleles would 
arise under the hypothesis of linkage (i.e. 0.00 < 9 < 0.5) to the 
probability that this distribution would occur randomly (i.e. 9 = 0.5). The 
ratio of these two possibilities is the odds ratio (L). For convenience, Lis 
converted to a decimal logarithm termed a lod score ("log of the odds"). 
An odds ratio of 100: 1 is therefore equivalent to a lod score of 2. 
The formula for the lod score (Z) is as follows: 
Z (9) = log10 L (0.00 < 9 < 0.5) 
L (9 = 0.5) 
Lod scor~s are a function of the recombination fraction and are 
calculated for a range of 8 ranging from 0.00 to 0.5. All lod scores are 
zero at 8 = 0.5, since they are then measuring the ratio of two identical 
probabilities, and log10(1) = 0. 
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Computer programs such as LINKAGE which implement the Elston-
Stewart algorithm (Terwilliger and Ott 1994) can be used to evaluate the 
likelihood of linkage of a given pedigree under different assumptions 
about the recombination fraction between the two loci. By convention, 
odds of more than 1000 to 1 (lod score of > 3) are necessary to prove 
linkage and odds ofless than 1 to 100 (lod score of< -2.00) are sufficient 
to reject the hypothesis of linkage. Values of Z between -2 and +3 are 
inconclusive. Once a disease gene is localised to a specific chromosomal 
region with sufficient precision, the application of other techniques such 
as positional cloning or the candidate gene approach can be used to lead 
to its eventual identification. 
3.1.2 This study 
3.1.2.1 The South African ad.RP families 
In this investigation, a genetic linkage analysis was utilised in an attempt 
to localise the gene responsible for the adRP phenotype in a large Sou,th 
African kindred. This fam1ly, designated RPD8, was chosen for study 
since it is one of the largest families from which DNA is.archived in the 
molecular genetics laboratory of the Department of Human Genetics, 
UCT. Family RPD8 is thought to have descended from a single ancestor 
from Hesse (a state in Western Europe, now Germany) who settled in 
South Africa in 1762. Most of the SA descendants live in the Gauteng 
and Free State Provinces of SA. 
Following the initial localisation of the adRP locus in family RPD8, the 
other large SA adRP families from which DNA had been banked, were 
investigated and a second family, designated RPD19, was linked to the 
same locus. This family is from the mixed ancestry population group and 
the majority of family members are resident in Cape Town in the Western 
Cape Province of SA. The pedigree structure and ophthalmological 
phenotype of families RPD8 and RPD 19 will be discussed in Section 
3.2.1. 
3.1.2.2 Experimental strategy 
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Random genome-wide screens using genetic linkage analysis require the 
use of DNA markers spaced at intervals not greater than 20 cM across 
the genome. A minimum of 200 markers is needed for the first line or 
initial screening which implies that this approach is rather time-
consuming and laborious. In order to optimise efforts to map the adRP 
gene with the laboratory's limited resources, a combination of genetic 
linkage analysis and candidate gene screening was embarked upon in 
this study. For retinal degenerative disorders, candidate genes include 
those which code for components involved in the light-activated rod 
phototransduction cascade, vitamin A (retinol) metabolism and the 
structure of the disc membrane. Candidate genes were chosen based on 
these criteria, and microsatellite markers situated in close proximity to 
the candidates were investigated for linkage to the adRP phenotype in 
family RPD8. 
3.2 PATIENTS, MATERIALS AND METHODS 
3.2.1 Patient recruitment 
All procedures used were reviewed and approved by the Research Ethics 
Committee at UCT (REC reference 044/95, March 1995). At the start of 
this investigation, the DNA of 29 members from family RPD8, including 
18 adRP affected individuals, was collected and available for study (Fig. 
3.1). Later in the investigation, an additional 15 family members were 
recruited and genotyped for inclusion in the analysis. The phenotypic 
expression of the disorder is consistent in the kindred and there is no 










Figure 3.1 Abridged pedigree of a South African adRP family designated RPD8. 
Legend: D - male, 
0 - female 
• e - affected adRP individual 





visual disturbance is between 20 and 30 years of age with night 
blindness often being the first manifestation. Family RPD 19 was later 
included in the linkage analysis and comprised 25 members, including 
nine affected individuals. 
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With informed consent, 20 ml of venous blood was collected from every 
individual who participated in the study. Genomic DNA was extracted 
from peripheral blood lymphocytes by standard techniques as described 
in Appendix B. The pedigree relationships in both families were 
confirmed by the appropriate segregation of all the tested microsatellite 
markers. 
Ophthalmological phenotype 
In order to emphasise the diagnostic status of the disorder in families 
RPD8 and RPD 19, ophthalmological reports concerning two adRP 
affected members from each family are presented below. 
i) Family RPD8: a 71-year-old female (individual IV-6, Fig. 3.1, page 41). 
[Report dated 1986; Dept. of Ophthalmology, University of 
Witwatersrand] 
This patient suffered from poor night vision from the age of 20 
years. When examined in late adulthood, her visual fields were 
extinguished. Her fundi showed pigmentary changes, very 
atrophic retina, pale optic discs and narrow blood vessels. 
Electroretinogram (ERG) studies showed absent blue, red and 
white photopic and scotopic responses as well as an absent 
flicker. These ERG findings were consistent with the diagnosis of 
retinitis pigmentosa. 
Fundus photographs of this individual are presented in Fig. 3.2. 
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Figure 3.2 Fundus photographs of an RP affected individual from family RPD8 . 
ii) Family RPD8: a 53-year-old male (individual V-15, Fig. 3.8, page 63). 
[Report dated 30 November 1995; Retinitis pigmentosa clinic, Groote 
Schuur Hospital, Cape Town] 
"He has a well documented · history of autosomal dominant 
retinitis pigmentosa with visual loss commencing in the 20's -
30's. He is at present aged 53 years and has noticed reduced 
visual fields and some reduction in central vision. On examination 
his corrected visual acuity measured 6/ 24 on the right and 6/ 18 
on the left. No abnormalities of the anterior segments were noted 
including no cataract formation. On dilated fund al examination 
the typical features of retinitis pigmentosa were noted, (viz. 1 waxy 
pallor of the optic nerve heads, retinal vascular attenuation, 
moderate clumping of the retinal pigment epithelium in the mid-
periphery extending to the equator, some retinal pigment epithelial 
atrophy underlying the macular and the retinal periphery). There 
is an early epiretinal membrane overlying both f oveas. In 
summary [this patient] has an autosomal dominant diffuse 
retinitis pigmentosa." 
iii) Family RPD19: a 44-year-old female (individual IV-2 , Fig. 3 .7 , page 62). 
[Report dated 7 November 1997; Retinitis pigmentosa clinic, Groote 
Schuur Hospital, Cape Town] 
"She has a family history of autosomal dominant retinitis 
pigmentosa. She first noticed decreased visual acuity at the age of 
28 with constriction of the peripheral fields and night blindness. 
On examination her best corrected visual acuities were 6/ 12 that 
improved to 6/ 9 with pinhole on the right and 6/ 9 on the left. 
Ishihara colour vision charts were 4/ 14 on the right and 6/ 14 on 
the left. She had macular threshold fields done to both eyes, 
which showed severe constriction of both visual fields, more so on 
the right. A dilated fundal examination revealed the typical 
44 
changes of retinitis pigmentosa. She has waxy pallor optic discs, 
and diffuse equatorial bone spicules. Her peripheral retina were 
flat and featureless, with areas of atrophy. She has perifoveal 
RPE atrophy. [This patient] has autosomal dominant retinitis 
pigmentosa with good central vision, but severely restricted, 
peripheral vision." 
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iv) Family RPD19: a 37-year-old female (individual IV-14, Fig. 3.7, page 62). 
[Report dated 15 September 1995; Retinitis pigmentosa clinic, Groote 
Schuur Hospital, Cape Town] 
"She has a family history of retinitis pigmentosa in that 2 bf her 
brothers, her fat her and her paternal grandmother were affected 
by the disorder. She complains of poor nocturnal vision but is 
managing well by day. She noticed change in her vision from the 
age of 7 but was diagnosed with retinitis pigmentosa at the age of 
22. On examination her best corrected visual acuities measured 
6/ 36 on the right and 6/ 24 on the left. No cataracts were present. 
On dilated fundal examination she was noted to have the typical 
features of retinitis pigmentosa including waxy pallor of the optic 
nerve heads, attenuation of the retinal vasculature, diffuse retinal 
pigment epithelial atrophy, bone spicule pigmentary deposits in all 
4 quadrants of the mid peripheral retina, and some slight retinal 
pigment epithelial atrophy underlying both maculae. On the left 
side she also had some foveal scarring." 
3.2.2 Genetic linkage analysis 
3.2.2.1 Candidate gene loci 
A screen of the seven adRP loci known at the time (viz. rhodopsin, 
peripherin/RDS and the anonymous loci on 8q, 7p, 7q, 19q and 17p) 
were the obvious candidate loci at which to initiate the genetic linkage 
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analysis. Subsequently, seven additional candidate gene loci were 
investigated for linkage (Table 3.1). These loci included components of 
the rod phototransduction cascade viz. the alpha (PDEA; Pittler et al. 
1990), beta (PDEB; Altherr et al. 1992) and gamma (PDEG; Dollfus et al. 
1993) subunits of PDE. To date, several members of this pathway, 
including rhodopsin, PDEA, PDEB and the alpha subunit of the rod 
cGMP-gated channel gene are known to be causative of various retinal 
dystrophies (Gregory-Evans and Bhattacharya 1998). Also chosen for 
study were the locus for Best macular dystrophy (Nichols et al. 1994), 
the locus for Usher syndrome Type IC (Keats et al. 1994), the neural 
retina-specific leucine zipper gene (NRL; Yang-Feng and Swar6op 1992) 
and the rod outer segment membrane protein 1 (ROM]) gene (Bascom et 
al. 1992b). 
All the available family members of RPD8 were genotyped with 
microsatellite DNA markers situated in close proximity to the 14 selected 
candidate gene loci. Two to three markers were chosen per locus 
(Table 3.1) from the Genethon human genetic linkage map which had 
been constructed using the Centre d'Etudes du Polymorphisme Humain 
(CEPH) reference families. The RHO-CA marker is an intragenic CA 
repeat within rhodopsin (Weber and May 1989) and a set of primers for 
this marker were synthesised at the Department of Biochemistry, UCT. 
All the other microsatellite markers listed in Table 3.1 were obtained 
from Research Genetics, Inc (USA). 
The rhodopsin locus was further investigated in family RPD8 using 
standard single strand conformation polymorphism (SSCP) techniques 
according to the method of Ori ta et al. 1989 (Appendix B) . The primers 
used to amplify exon 3 of rhodopsin are: forward 5'-TTg gCT gTT CCC 
AAg TCC CT-3' and reverse 5'-TCC AgA CCA Tgg CTC CTC CA-3' 
(Inglehearn et al. 1992). 
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Table 3.1 Markers used to test linkage of adRP in family RPD8. 
rhodopsin 3q D3S621 0.79 
RHO-CA 0.34 
peripherin/RDS 6p D6S260 0.84 
D6S291 0.70 
D6S257 0.86 
RPI locus 8q D8S166 0.88 
D8S165 0.54 
D8S285 0.79 
RP9 locus 7p D7S460 0.95 
D7S484 0.75 
D7S435 0.59 
RPlO locus 7q D7S480 0.87 
D7S496 0.76 
D7S487 0.75 
RPll locus 19q D19S180 0.72 
D19S2l4 0.64 
Dl9S254 0.78 
RP13 locus 17p Dl 7S849 0.68 
Dl 7S796 0.82 
Dl 7S938 0.90 
Best disease locus llq D11S937 0.88 
Dl 1S911 0.86 
INT2 0.85 
Usher syndrome type IC llp Dl 1S902 0.81 
D11S904 0.83 
NRL locus 14q Dl4S64 0.77 
Dl4S50 0.77 
Dl4S70 0.77 
ROMl locus llq D11S956 0.88 
Dl 1S916 0.74 
PDEA locus Sq D5S403 0.65 
D5S393 0.84 
D5S2l0 0.75 
PDEB locus 4p D4S227 0.73 
D4S403 0.78 
PDEG locus 17q Dl 7S798 0.80 
Dl 7S800 0.74 
Dl 7S809 0.72 
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A total of 29 highly polymorphic markers was used to investigate linkage 
to chromosome 1 7 q in families RPD8 and RPD 19 (Table 3. 2). The 
Genethon chromosome 17 genetic linkage map (Fig. 3.3) illustrates the 
most likely order and the sex average recombination fractions calculated 
between adjacent markers. 
3.2.2.2 Polymerase chain reaction 
Genotypes were interpreted from the polymerase chain reaction (PCR) 
amplification of alleles from the microsatellite repeat polymorphisms. 
Detection of PCR products was achieved by two methods: 
i) Radioactive labelling. The forward primer was first end-labelled using 
T4 polynucleotide kinase and [x32P]ATP before being added to the PCR 
reaction. The standard PCR reaction was performed in a 10 µl volume 
containing 200 ng genomic template DNA, 2.5 pmol of each primer, 1.5 
mM MgC12 , 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1 % Triton X- 100, 
250 µM of each dNTP and 0.6 units (U) of Taq DNA polymerase (Promega, 
USA or GIBCO/BRL, USA). Amplification was carried out by denaturing 
at 94°C for 3 min, followed by 30 cycles at 94°C for 1 min, 55°C (50°C for 
some primers) for 1 min and a final extension of 7 min at 72°C on an 
Omnigene Thermal Cycler (Hybaid, USA). An overlay of liquid paraffin 
was added to each sample to prevent evaporation during the PCR 
reaction. 
Three microlitres of formamide loading dye (Appendix C) was added to 3 
µl of the PCR product and denatured on a heating block at 95°C for 5 
min. The samples were placed on ice before loading on 6% denaturing 
polyacrylamide gels (Appendix C). The gels were electrophoresed at 60 -
70 watts (W) in a lX TBE running buffer, using the marker dyes in the 
formamide loading dye to determine at which point the repeat fragments 
Table 3.2 The 29 polymorphic microsatellite markers used to test linkage of 







Dl 7S787 0.81 
D17S1607 0.66 
D17S1606 0.88 






Dl 7S1835 0.70 
D17S808 0.67 
D17S924 0.63 
Dl 7S794 0.74 
Dl 7S1874 0.75 
Dl 7S807 0.85 
D17S942 0.66 
Dl 7S795 0.80 
Dl 7S789 0.82 
D17S840 0.63 
Dl 7S949 0.80 
D17S929 0.52 
D17S785 0.83 
Dl 7S939 0.83 










































Figure 3.3 Abridged diagram of the CEPH/Genethon human genetic linkage map on 
part of chromosome 17 q ( January 1996). 
would be fully resolved. At the end of the run, the gels were transferred 
onto Whatmann 3MM paper, dried on a Hoeffer Slab Gel Dryer at 80°C 
for 1 hour and exposed to X-ray film (Agfa Curix, Germany) overnight 
(0 /N) at -70°C, with intensifying screens. The following day, the X-ray 
film was developed in Cronex developer and fix solutions (Protea, South 
Africa) and the genotypes ascertained. 
51 
ii) Fluorescent labelling. Genomic template DNA was amplified in 10 µl 
reactions containing 3.5 ng of each primer (the 5' end of one primer was 
labelled with a fluorescent dye), 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 
0.1% Triton X-100, 1.5 mM MgCb, 200 µM of each dNTP and 
1
0.6 U of 
Taq DNA polymerase (Promega, USA). Amplification conditions were the 
same as for radioactively labelled PCR. The amplification products were 
separated on 6% polyacrylamide gels on an Applied Biosystems Inc. 
Model 373 DNA Sequencing System (USA) according to the 
manufacturer's instructions. GENESCAN 672 software allowed 
automated laser scanning and detection of fluorescent PCR products and 
eliminated the need for post-run gel handling. 
3.2.2.3 Two point lod scores 
Two-point lod scores were calculated using the LINKAGE package of 
pq)grams, version 5.1 and the MLINK and ILINK core programs (Lathrop 
et al. 1984), from data prepared by the LINKSYS data management 
package (Attwood and Bryant 1988). Male and female recombination 
rates were taken to be equal. The oldest age of onset of the disorder in 
family RPD8 was 40 years and for this reason, asymptomatic individuals 
younger than 40 years were omitted from the analysis. A full penetrance 
and a gene frequency of O.0001 for the disease locus were assumed for 
the computation of all lod scores. 
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3.2.2.4 Multipoint linkage analysis 
Multipoint linkage is usually performed to locate a disease locus on a 
fixed framework of markers. This analysis was attempted because 
linkage analysis can be more efficient if data for more than two loci are 
analysed simultaneously. Several overlapping four-point analyses (three 
markers and the disease locus) were calculated, computing the lod score 
at each map point within each interval. This multipoint analysis was 
performed using LINKMAP (Lathrop et al. 1984) and run at the Human 
Genome Mapping Project Resource Centre's computing facilities in 
London, UK and the VAX at the University of Cape Town, SA. 
3.2.3 Construction of haplotypes 
Recombination events rarely separate loci which lie very close together, 
therefore sets of alleles on the same small chromosomal segment tend to 
be transmitted as a block (or haplotype) through a pedigree. Haplotypes 
can be treated for mapping purposes as alleles at a single highly 
polymorphic locus. A subset of polymorphic microsatellite markers 
situated close together on chromosome 17q were used for the 
construction of haplotypes for members of families RPD8 and RPD 19. 
3.3 RESULTS 
3.3.1. Exclusion of 14 candidate loci 
All the available family members of family RPD8 were genotyped with 38 
polymorphic markers from a total of 14 candidate gene loci. Two point 
lod score analyses between each marker and the disease phenotype are 
presented in Table 3.3. Significantly negative lod scores of Z less than -
2.00, providing evidence for exclusion, were obtained for all the 
candidate loci except rhodopsin. The family was uninformative for the two 
markers chosen at this locus viz. RHO-CA and D38621. Further 
Table 3.3 Two point lod scores (Z) calculated between adRP in family RPD8 and 
microsatellite markers situated close to candidate gene loci. 
RECOMBINATION FRACTION (0) 
Gene Marker 0.001 0.05 0.10 0.15 0.20 
rhodopsin D3S621 -0.97 -0.60 -0.38 -0.25 -0.15 
RHO-CA 0.18 0.15 0.12 0.10 0.07 
peripherin/RDS D6S260 -16.3 -5.16 -3.11 -1.99 -1.28 
D6S291 -15.63 -4.44 -2.59 -1.62 -1.01 
D6S257 -16.70 -2.58 -1.20 -0.56 -0.23 
RPl locus D8S166 -12.46 -1.90 -1.11 -0.78 -0.62 
D8S165 0.49 0.50 0.47 0.42 0.36 
D8S285 -6.77 -1.40 -0.51 -0.13 0.04 
RP9 locus D7S460 0.49 0.50 0.47 0.42 0.36 
D7S484 -14.53 -3.95 -2.53 -1.71 -1.16 
D7S435 -19.00 -3.87 -2.30 -1.43 -0.89 
RPlO locus D7S480 -2.30 -2.30 0.59 0.62 0.59 
D7S496 -11.93 -1.42 -0.39 0.05 0.23 
D7S487 -10.85 -1.58 -0.54 -0.07 0.16 
RPll locus D19S180 -14.24 -5.15 -2.90 -1.74 -1.04 
D19S214 -6.16 -1.62 -1.07 -0.79 -0.60 
D19S254 -14.35 -3.31 -1.76 -0.99 -0.55 
RP13 locus D17S849 -15.20 -3.78 -2.42 -1.67 -1.19 
D17S796 -oo -0.47 -0.03 0.14 0.22 
D17S938 -oo 0.31 0.66 0.75 0.74 
Best macular D11S937 -15,15 -3.84 -2.15 -1.26 -0.72 
dystrophy Dl1S911 -17.70 -3.42 -1.73 -0.87 -0.38 
INT2 -21.86 -4.83 -2.88 -1.84 -1.20 
Usher Type 1 C Dl 1S902 -13.20 -4.08 -2.47 -1.56 -0.99 
Dl 1S904 -17,89 -4.45 -2.71 -1.76 -1.15 
NRL D14S64 -14.20 -1.35 -0.12 0.41 0.64 
D14S50 -17.82 -2.65 -1.16 -0.44 -0.05 
D14S70 -12.39 -2.15 -0.95 -0.38 -0.09 
ROMl D11S956 -18.88 -4.94 -3.04 -2.06 -1.46 
Dl1S916 -17.82 -2.40 -0.86 -0.14 0.28 
PDEA D5S403 -21.30 -7.32 -4.84 -3.45 -2.51 
D5S393 -20.90 -6.53 -4.20 -2.93 -2.09 
D5S2l0 -10.70 -1.01 -0.27 0.06 0.20 
PDEB D4S227 -13.16 -3.78 -1.89 -0.94 -0.39 
D4S403 -17.28 -5.15 -2.95 -1.81 -1.11 
PDEG D17S798 -10.24 -3.32 -1.89 -1.14 -0.67 
Dl7S800 -8.68 -1.77 -0.75 -0.26 -0.00 









































investigation of rhodopsin, using SSCP analysis revealed a neutral 
polymorphism in exon 3 of the gene, which was informative in a nuclear 
section of family RPD8 (data not shown). A recombination event was 
detected thereby excluding rhodopsin from being the gene causative of 
the disorder. 
The results presented in Table 3.3 provide evidence for the exclusion of 
the involvement of all seven known adRP loci in this family. Hence, the 
existence of a novel adRP locus for family RPD8 was firmly established. 
3.3.2 Linkage to chromosome 17g 
Evidence of linkage in family RPD8 was first detected when a marker on 
chromosome 17q, situated in close proximity to the PDEG gene, was 
genotyped in the family. A promising lod score of Z = 1. 91 was obtained 
at e = 0 .15 for the marker D 1 7S809. In order to further investigate this 
tentative linkage result, the kindred was genotyped with additional 
markers situated approximately 15 cM distal and proximal to Dl 7S809. 
Significantly positive lod scores indicative of linkage were obtained and 
no recombination ·events were observed between the disorder and the 
following markers: D17S790, D17S787, D17S808 and D17S807 
(Table 3.4). Flanking recombinants were detected by Dl 7S809 and 
D 17S942, which provisionally places the adRP locus in this interval. In 
order to locate the disease locus on the framework of microsatellite 
markers, multipoint analysis was performed using D 1 7S808, D 17S807, 
D 17S942 and D 17S789; this yielded a maximum lod score of 8.28 for the 
adRP locus between Dl 7S808 (proximal) and Dl 7S807 (distal) as shown 
in Fig. 3.4. This was the eighth locus identified for adRP (Bardien et al. 
19_95) and has been designated RP17 (MIM 600852). 
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Table 3.4 Two point lod scores (Z) between adRP and markers on chromosome 
17q. Maximum lod scores at corresponding recombination fractions are 
shown in bold type. 
I RECOMBINATION FRACTION (9) 
/DNA 0.00 0.01 0.05 0.10 0.20 0.30 0.40 Zmax emax 
marker 
cen 
D17S809 -00 -0.31 1.42 1.85 1.76 1.23 0.52 1.90 0.13 
D17S790 0.32 0.31 0.28 0.23 0.15 0.09 0.04 0.32 0.00 
D17S787 1.23 l.20 1.08 0.97 0.77 0.55 0.30 1.23 0.00 
Dl 7S808 4.63 4.53 4.14 3.63 2.56 1.46 0.44 4.63 0.00 
Dl 7S807 5.69 5.62 5.26 4.75 3.61 2.38 1.09 5.69 0.00 
D17S942 -oo 4.07 4.38 4.17 3.39 2.36 1.14 4.38 0.04 
Dl 7S795 -oo 2.98 3.36 3.23 2.61 1.78 0.80 3.36 0.05 
D17S789 -00 5.31 5.47 5.09 3.96 2.65 1.24 5.52 0.03 
D17S929 -00 -4.39 -1.77 -0.79 -0.05 0.17 0.16 0.19 0.34 
Dl 7S785 -00 -1.68 -0.41 0.03 0.31 0.31 0.20 0.33 0.25 
tel 
Asymptomatic individuals below 40 years of age were omitted from the lod score 
analysis. 
-0.2 -0. 1 
D17S807 



















3.3.3 Fine mapping of the adRP locus 
To facilitate the fine mapping of the RP 17 locus, family RPD8 was 
genotyped with a further 17 microsatellite markers on chromosome 17q. 
In addition, DNA of three more family members was collected for study 
(individuals VI-2, VI-7 and VI-11; Fig. 3.5) and their genotypes were 
included in the linkage analysis. 
Two point lod scores obtained between the adRP locus and the series of 
markers are presented in Table 3.5. These data confirm the initial 
linkage results and indicate that the RPl 7 locus maps to the 11 cM 
interval (converted by the Haldane map function) between Dl7S1607 and 
D 17S187 4. In order to identify the most likely location of the ad RP gene 
relative to the new series of markers, a subset of the loci from Table 3.5 
was used to generate a multipoint map of the region (Fig. 3.6). The adRP 
locus was moved up to and in between the eight fixed loci: D 17S809, 
D17S787,D17S1607,D17S957,Dl7S792,Dl7S944,Dl7Sl874ending 
at D 17S795 which spans a total genetic distance of approximately 18 cM 
(Haldane map function). The multipoint graph peaked at a lod score of 
9.15 at D 17S944 and the 3-unit-of lad-score support interval (a more 
meaningful support interval in multipoint analysis; Terwilliger and Ott 
1994) encompasses a region between D17S1607 and D17S1874, 
indicating the most likely interval containing the disease gene. Further 
evidence for this localisation is provided by the construction of disease-
associated haplotypes, which illustrate meiotic recombination events 
between the disease phenotype and D 1 7 S 1607 and D 17S187 4 in family 
RPD8 (Fig. 3.5). Individual IV-4 is recombinant for markers Dl 7S1874, 
D17S807 and D17S942; and individual VI-1 is recombinant for 
D17S790, D17S787 and D17S1607. 
The two-point, multipoint and haplotype data provided here together 
confirm and refine the localisation of RPl 7 to an 11 cM interval on 
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Figure 3.5 Haplotypes were constructed for members.of family RPD8 at 15 chromosome 
















Table 3.5 Pairwise lod scores between adRP and anonymous markers on chromosome 17q. 
cen 
D17S798 -10.24 - -3.32 -1.89 -0.67 -0.16 0.02 0.00 
D17S800 -20.02 -5.41 -2.42 -1.27 -0.39 -0.09 -0.01 0.00 
D17S934 -4.22 -0.72 -0.10 0.09 0.18 0.15 0.07 0.00 
D17S809 -10.77 0.52 2.18 2.52 2.25 1.54 0.66 0.00 
D17S790 0.41 0.40 0.37 0.32 0.22 0.13 0.06 0.00 
D17S787 1.68 1.65 1.55 1.41 1.09 0.75 0.38 0.00 
D17S1607 5.21 4.83 3.69 2.35 0.95 0.00 
D17S957 3.29 3.09 2.78 2.04 1.21 0.40 0.00 
D17S923 2.89 2.57 2.15 1.33 0.59 0.10 0.00 
D17S792 4.93 4.51 3.97 2.84 1.65 0.58 0.00 
D17S948 4.57 4.19 3.71 2.73 1.74 0.75 0.00 
D17S944 8.17 7.56 6.77 5.11 3.33 1.49 0.00 
D17S1835 3.89 3.55 3.09 2.10 1.10 0.30 0.00 
D17S808 5.76 5.37 4.81 3.55 2.15 0.75 0.00 
D17S924 3.84 3.58 3.22 2.41 1.54 0.64 0.00 
D17S794 3.03 2.75 2.37 1.53 0.74 0.18 0.00 
D17S1874 4.63 4.43 3.60 2.50 1.20 0.00 
D17S807 6.39 6.32 5.95 5.40 4.11 2.71 1.23 0.00 
D17S942 -00 4.25 4.55 4.33 3.50 2.43 1.17 0.00 
Dl 7S795 -00 3.00 3.43 3.34 2.72 1.84 0.82 0.00 
D17S789 -oo 5.03 5.19 4.80 3.68 2.43 1.11 0.00 
D17S840 -4.72 -0.69 -0.04 0.14 0.17 0.10 0.04 0.00 
D17S949 -00 4.82 5.07 4.79 3.84 2.65 1.28 0.00 
D17S929 -17.98 -4.07 -1.47 -0.51 0.14 0.28 0.20 0.00 
D17S785 -7.59 -1.55 -0.28 0.15 0.39 0.36 0.21 0.00 
D17S939 -8.18 -2.14 -0.86 -0.40 -0.08 -0.01 -0.00 0.00 
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Figure3.6 Multipoint linkage analysis between adRP and D17S809, DI7S787, D17St607, D17S957, D17S792, D17S944, D17St874 & D17S795. 
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3.3.4 Linkage of a second adRP family to 17q 
Subsequent to the mapping of RPI 7, all large unlinked South African 
adRP families from which DNA is archived in the molecular genetics 
laboratory at UCT were investigated for linkage to 17q22. A second 
family, designated RPD 19 (Fig. 3. 7) was shown to be linked to this locus 
(D17S948, Z = 5.45; D17S944, Z = 5.40; D17S808, Z = 4.31, 
all ate = 0.00; Bardien et al. 1997). 
3.3.5 Further refinement of RPl 7 to a 1 cM interval 
The 11 cM interval within which the adRP gene was mapped was not yet 
sufficiently small to consider physical mapping and positional cloning 
approaches in efforts to identify the gene. Additional linkage analyses 
were embarked upon in an attempt to further refine the RPI 7 critical 
interval and after intensive investigations, DNA from an additional 12 
members (including six affected persons) from family RPD8 was collected 
and genotyped. Haplotypes were constructed for family RPDl 9 (Fig. 3.7) 
and for a total of 44 members of family RPD8 (Fig. 3.8) using a selected 
subset of markers on 17q22. Although the two kindreds are of different 
population groups, the affected individuals from the two families exhibit 
the same disease-associated alleles and haplotype, comprising 17 
markers spanning an interval of 12 cM. This observation indicates that 
the two families share a common ancestor. 
The observation of recombination events in informative meioses 
facilitated the refinement of the RPI 7 locus to a 1 cM critical interval. 
One individual, V-15 (Fig. 3.8) is recombinant for the markers D 17S790 
through to D 1 7S 1604 and it is evident that in this person, the 
maternally inherited chromosome had recombined. Individual V-15 is an 
unequivocally adRP affected male aged 55 years and on dilated fundal 
examination, was found to have typical features of RP (Ophthalmologist's 
I 
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Figure 3.7 Pedigree of family RPD19. The disease-associated haplotype is shown in a box beneath each individual. Individuals 
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Figure 3.8 Pedigree of family RPD8 illustrating the segregation of the disease-associated 



















report in Section 3.2.1, page 44). This recombinant provides conclusive 
evidence that the adRP gene maps distal to D 1 7S 1604. 
Unaffected individual III-8 {Fig. 3. 7) is recombinant for the mar.kers 
D 1 7S948 through to D 1 7S942 and it is her maternally inherited 
chromosome which had recombined. Individual III-8 had died at age 73 
and had not shown. any symptoms of visual problems up to her death, 
except for the presence of cataracts. The construction of haplotypes 
reveals that three of her four offspring {individuals IV-5, IV-6 and IV-7) 
had inherited the recombined chromosome from their mother. They are 
all over 50 years of age and on ophthalmologic examination did not 
exhibit any manifestations indicative of RP. This recombinant provides 
evidence that the adRP gene maps proximal to D 17S948. 
In conclusion, by combining the haplotype data obtained from the two 
families, it was possible to further delimit the critical interval for RPl 7 
from a 11 cM to a 1 cM interval between Dl 7S1604 and Dl 7S948 
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(Fig. 3.9) [Bardien-Kruger et al. 1999]. This refined region is sufficiently 
small to facilitate positional cloning techniques in an attempt to identify 
the defective gene. 
3.4 DISCUSSION 
As discussed in Chapter One, there is a high level of genetic 
heterogeneity, both allelic and non-allelic, within RP. An inevitable 
benefit of this heterogeneity would be the characterisation of a large 
number of biologically important retina expressed genes and an increase 
in the understanding of the functioning of the healthy retina. This 
dissertation reports the mapping of a novel adRP locus (designated RPl 7) 
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Figure 3.9 An ideogram of chromosome 17q depicting the position of the RPI 7 locus 
relative to microsatellite markers on 17q22. 
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following rhodopsin, peripherin/RDS and anonymous loci on 8q, 7p, 7q, 
19q and 17p. Subsequently, a ninth locus for adRP has been mapped to 
chromosome lq (Xu et al. 1996). 
The two 17q-linked adRP families are members of different South African 
population groups (Afrikaner and mixed ancestry) and according to 
genealogical data, are apparently unrelated. It is noteworthy, however, 
that they share a common disease-associated haplotype, which indicates 
that the same mutation of the same gene accounts for adRP in both 
families. 
The refined localisation of RP 1 7 by genetic mapping provides a step 
towards the identification of the adRP gene; and delineation of a 1 cM 
region defines a realistic target for subsequent isolation of the gene by 
positional cloning techniques. The 1 cM critical interval mapped for RPl 7 
may be considered small by genetic standards but relates to about 1 Mb 
of DNA. Given an average gene density of 5 genes per 100 kb for the 
human genome (Strachan and Read 1996), it is possible that more than 
50 separate genes may reside in this interval. The next step towards 
isolating the RPl 7 gene would be the identification and subsequent 
characterisation of each of these genes, which would then have to be 
tested individually for evidence linking them to the adRP phenotype. 
Several different techniques may be used to isolate genes from a specific 
region of mammalian DNA, and they generally fall into two basic 
categories i.e. cDNA-based approaches and genome-based approaches. 
The degree of success achieved with each of these methods is variable 
due to their inherent strengths and weaknesses. It is estimated that only 
about 3% of the mammalian genome codes for genes which are often 
separated by large intergenic (non-coding) DNA tracts. One way to tackle 
the problem of identifying genes in genomic DNA has been to find CpG 
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islands. In a study using fluorescent in situ suppression hybridisation to 
metaphase chromosomes, chromosome 17 was found to have a high CpG 
isla.nd density, thereby implying that it is a gene-rich chromosome (Craig 
and Bickmore 1994). 
Other retinopathies that have been mapped to human chromosome 1 7 
include: 
i) an adRP locus (RP13) on 17p13.3 (Greenberg et al. 1994a), 
ii) Leber's congenital amaurosis Type I (LCAl) on 17pl3. l associated 
with mutations in the gene for retinal guanylate cyclase (Perrault 
I 
. et al. 1996), 
iii) progressive cone dystrophy (CORDS) on 17pl3-12 (Balciuniene et 
al. 1995), 
iv) cone-rod dystrophy (CORD6) on 17p13-12 associated with 
mutations in the gene for retinal guanylate cyclase (Kelsell et aL 
1998), 
v) Sjogren-Larsson syndrome on 17pl 1.2 caused by mutations in the 
fatty aldehyde dehydrogenase gene (De Laurenzi et al. 1996), 
vi) central areolar choroidal dystrophy (CACD) on 17p (Lote:ry et al. 
1996), 
vii)· cone-rod dystrophy locus (CORD4) on 17ql 1 (Kylstra and 
Aylsworth 1993). 
From this list, it is evident that chromosome 17p is a hot spot for several 
phenotypically distinct retinal disorders. These differences in phenotypic 
manifestations may be due to genetic heterogeneity, allelic heterogeneity 
or the presence of epistasis (Joshi et al. 1997). Several retinally 
expressed genes have been assigned to chromosome 1 7. On the short 
arm these include the genes coding for: recoverin (RCVl, Murakami et al. 
1992), retinal guanylate cyclase 2D ( G[fC2D, Oliveira et al. 1994), 
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pigment epithelium-derived factor (PEDF, Tombran-Tink et al. 1994), 
phosphatidylinositol transfer protein (PITPN, Fitzgibbon et al. 1994) and 
beta-arrestin 2 (ARRB2, Calabrese et al. 1994). On the long arm, the 
retinal fascin gene, which may play a role in photoreceptor cell disc 
morphogenesis, has been localised to 17qter by fluorescent in situ 
hybridisation (FISH) techniques (Saishin et al. 1997). In addition, the 
PDEG gene, one of the components of the rod phototransduction 
pathway, has been genetically linked to 17q25 (Dollfus et al. 1993). 
Retinal fascin and PDEG are both attractive candidates for RP 17 and it 
would be appropriate for them to be investigated for pathogenic 
mutations in the two 17q-linked adRP families. 
At the level of comparative gene mapping, human chromosome 17 is 
evolutionarily conserved with chromosomes from other animal species. 
This chromosome displays considerable synteny with mouse 
chromosome 11 (O'Brien et al. 1993) and according to the NCBI Genbank 
Human to Mouse Homology Maps 
(http://www.ncbi.nlm.nih.gov/ Omim/Homology /human 17.html) more 
than 100 gene loci from human chromosome 17 are represented on 
mouse chromosome 11. To date, there are, however, no obvious 
candidates for RP in the region corresponding to RPl 7 in mice. 
Furthermore, bovine chromosome 19 is thought to be entirely and 
exclusively conserved with chromosome 17, nevertheless, 
rearrangements in the linear order of homologous genes are apparent 
between the two chromosomes (Yang et al. 1998). Canine chromosome 9 
shares synteny with the long arm of chromosome 17, using FISH 
analysis and linkage mapping but the gene order in the dog is inverted 
with respect to the centromere (Werner et al. 1997, Acland et al. 1998). 
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A locus for progressive rod-cone degeneration (prcd) has been mapped to 
dog chromosome 9 and based on the phenotype and the synteny between 
the two chromosomes it is proposed that this is the canine homologue of 
RP17 (Acland et al. 1998). Further investigations are required to 
determine if these two loci are orthologous. Prcd is inherited as an 
autosomal recessive trait and is present as an allelic condition in several 
breeds (miniature and toy poodle, English and American cocker spaniel, 
Labrador retriever and Portuguese water dog). In this condition, first the 
rods and then the cones degenerate both structurally and functionally 
after apparently normal postnatal development. The prcd gene has not 
yet been identified. 
Construction of a high-resolution physical map of chromosome 17 has 
made extensive use of somatic cell hybrids carrying various deletions and 
translocations of this chromosome. These hybrid mapping panels have 
played an important role in the regional localisation of numerous 
anonymous probes and cloned genes. Other mapping reagents or 
resources currently available include a Notl linking library constructed 
for 17q (Borrow et al. 1991), a high-density genetic map of 17q12-21 
(Anderson et al. 1993), somatic cell hybrid mapping panels spanning the 
17q22-24 region (Flejter et al. 1993), and a high-resolution radiation 
hybrid map of 17q22-25.3 covering the region from the growth hormone 
gene (GH) to the thymidine kinase gene (TK) (Foster et al. 1996). These 
reagents could prove useful in attempts to clone the RPl 7 gene. 
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Summary: 
This chapter describes the construction of a physical map 
for the RPl 7 locus using sequence-tagged-site content 
mapping. The completed contig comprises seven YACs and 
two BACs which span the 1 cM critical interval. In an 
attempt to construct a transcription map of the region, the 
cDNA selection technique was applied to one of the YACs 
from the contig using a foetal brain cDNA library. Two 
rounds of selection were performed and the technique was 
accomplished successfully as indicated by the positive 
reporter gene. The sub-library created for enriched cDNAs 
derived from YAC 751c12 consists of a total of 480 selected 
transformants. This library was subsequently screened for 
the presence of contaminating sequences i.e. human COT-1 
DNA and total yeast AB1380 DNA and 7% of the clones were 
found to contain repetitive sequences. Ten randomly 
chosen transformants. were sequenced and subjected to 
BLASTN homology searches. 
4.1 INTRODUCTION 
The construction of detailed physical maps of the human genome is an 
important tool for the identification and cloning of genes causative of 
inherited disorders. Over the last decade, significant time and effort has 
been invested in establishing genomic libraries that cover the entire 
genome in relatively small overlapping fragments. 
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4.1.1 Yeast artificial chromosomes 
Yeast artificial chromosomes (YA Cs; Burke et al. 1987) have led the way 
in mapping complex genomes and YAC libraries now cover a large part of 
the human genome. The various components of a typical YAC are 
presented in Fig. 4.1. One of the major advantages of these vectors is 
their ability to contain the complete genomic region of large genes, 
including the promoter sequences and upstream control elements. There 
are several major problems, however, that need to be considered when 
working with YAC clones. One disadvantage is the high number of YACs 
(40-60%) that are chimaeric i.e. containing two or more fragments 
derived from non-contiguous segments of human DNA. A second problem 
is that some clones are unstable and tend to delete internal regions from 
their inserts which could be deleterious in gene isolation experiments or 
when constructing physical maps of specific chromosomal regions. A 
third major disadvantage is that the YAC DNA cannot be isolated from 
the 15 Mb yeast host chromosome background by simple methods. In 
order to overcome some of these problems, several alternative cloning 
systems have been developed e.g. bacterial artificial chromosomes 
(BACs), Pl-derived artificial chromosomes (PACs) and cosmids (which 
contain a bacteriophage lambda cos site) and these are summarised in 
Table 4.1. 
4.1.2 Construction of contigs 
To ensure that that there is complete representation of the genomic 
region of interest, and no gaps, the series of clones should contain 
overlapping inserts forming a comprehensive clone contig. In principle, 
contig assembly is facilitated by the way in which genomic DNA libraries 
are constructed. As part of the protocol, the genomic DNA is deliberately 
subjected to partial digestion with a restriction endonuclease e.g. EcoRl 
before being cloned into the vector. As a result, individual genomic DNA 
TEL TRPl ARS CEN URA3 TEL 
.-o-~-o c=J--+ 
LeftYAC arm human DNA insert Right Y AC arm 
Figure 4.1 Schematic diagram of a Y AC cloning vector, illustrating the telomeres (TEL) at either end, yeast 
selectable markers TRPl and URA3, an autonomously replicating sequence (ARS), a yeast 
centromere (C:EN), and a large human DNA insert. 
Telomeres confer structural integrity upon linear DNA molecules and centromeres confer 
the property of accurate mitotic and meiotic segregation upon either circular or linear plasmid DNA. 





Table 4.1 Cloning vectors used in the positional cloning strategy. 
YAC S. cerevisiae 100-2000kb 
PAC E.coli 100-300 kb 
BAC E.coli 130-300 kb 
Pl clone E.coli 70-100 kb 
Cosmid E.coli 35-45 kb 
clones usually contain DNA sequences that partially overlap with other 
clones in the library. 
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One widely used technique for identifying clones with overlapping ins'erts 
is using a specific DNA probe from one clone to screen the rest of the 
library; This involves the purification and labelling of terminal sequences 
from the insert DNA of the starting clone i.e. an end-probe. Positively 
hybridising clones can then be purified and new, distal end-probes can 
be prepared· for further rounds of hybridisation screening of the library. A 
popular method for generating end-probes is vectorette PCR (or bubble 
linker PCR; Riley et al. 1990). In this technique, the clone DNA is 
digested with a restriction endonuclease and the digestion products are 
ligated to a double-stranded oligonucleotide linker designed to have non-
complementary oligonucleotides in the middle, forming a "bubble"-shape. 
Using these vectorette libraries as templates, a PCR reaction is performed 
with a linker-specific primer and a vector-specific primer, which permits 
amplification of the uncharacterised insert sequence flanking the vector 
arm. In this way, the clone insert terminal sequences can be isolated and 
made available for further manipulation. 
Vectorette PCR and other such techniques e.g. inverse PCR (Ochman et 
al. 1988), permits the assembly of a clone contig by bi-directional 
chromosome walking from a fixed starting point. Since YAC clones often 
have chimaeric inserts, however, the chromosomal location of any new 
YACs identified in a YAC walk always ought to be verified by FISH 
analysis. 
Chromosome walking is a highly directional and location-restricted 
procedure for generating clone contigs. In order to assemble contigs 
rapidly over large fractions of the genome, random clone fingerprinting 
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methods are preferred. Some examples of these methods are: 
i) Repetitive DNA fingerprinting 
In this technique, the large component of highly repetitive interspersed 
DNA sequences e.g. human Alu and LINE-1 repeats are used to generate 
repetitive DNA fingerprinting patterns of YA Cs. LINE-1 repeats occur 
about once every 50 kb and the full-length consensus sequence is 6.1 kb 
long. Clones with overlapping inserts are identified by similar patterns 
obtained, following digestion with a suitable restriction endonuclease and 
hybridisation with repetitive DNA probes. 
ii) Sequence-tagged-site content mapping 
Sequence-tagged-sites (STSs) are PCR-based markers that are unique for 
a specific known sequence of DNA. Microsatellite markers (described in 
Section 3.1.1.1) are a subset of STSs and they represent a critical link 
between genetic and physical maps. If numerous individual STS 
sequences have been positioned on a chromosome and YACs have been 
mapped to the same general area (e.g. by FISH) then the ability to type 
for STSs, allows a rapid and convenient method for identifying YACs with 
overlapping sequences i.e. STS-content mapping. For a typical STS, 
primers of approximately 20 bp are designed for use in a standard PCR 
reaction. Even for a complex genome, the probability of both primers 
binding non-specifically to sequences in close proximity and in the 
correct orientation is extremely low. By size-fractionation of the PCR 
products on an agarose gel and obtaining a single DNA band of the 
expected size, there is a good chance that the assay is specific for the 
intended target sequence. 
iii) Hybridisation with interspersed repeat elements (IRE)-PCR 
Hybridisation using IRE-PCR is a PCR reaction in which only a single 
primer is used, corresponding to a common repetitive element. An 
example is Alu-PCR (or inter Alu-PCR) in which the primer is derived 
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from Alu sequences, which occur on average every 4 kb in the human 
genome. The single primer binds to the repetitive elements and if they are 
in close enough proximity, allows amplification of the sequence between 
them. These products can then be used as probes for screening other 
YACs. 
4.1.3 Isolation of gene transcription units 
Once a continuous, overlapping clone contig has been assembled for the 
region of interest, the individual clone insert DNA can be examined for 
gene transcription units. As mentioned previously, purification of YAC 
DNA is not a simple task because YACs have a very similar structure to 
the natural yeast chromosomes. Techniques such as separation by 
pulsed-field gel electrophoresis (PFGE) or direct subcloning of the entire 
yeast genome into bacteriophage vectors, followed by identification of 
human-specific clones derived from the YAC, are usually required. 
During a PFGE run, the relative orientation of the gel and the electric 
field is periodically altered; and the DNA molecules are intermittently 
forced to change their conformation and direction of migration. The time 
taken for a DNA molecule to alter it conformation and re-orient itself in 
the direction of the new electric field is strictly size dependant, and as a 
result, DNA fragments of up to several megabases in size can be 
fractionated efficiently using this method. 
The rate limiting steps in the positional cloning of disease-causing genes 
are the identification of discrete genes within a large genomic region and 
the analysis of mutations within these genes. A number of strategies, 
summarised in Table 4.2, have been developed to isolate transcription 
units in complex genomes, which by definition contain a small 
percentage of coding sequences amidst a sea of non-coding sequences. 
Some of these methods are relatively straightforward and involve using 
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a. Hybridisation to RNA/cDNA -
b. Evolutionary conservation (zoo Claudio et al. 1994 
blots) 
c. Identification of CpG islands Larsen et al. 1992 
d. Direct cDNA library screening Elvin et al. 1990 
e. cDNA selection Parimoo et al. 1991/Lovett et al. 1991 
II. Function-based 
a. Splice-junctions - exon trapping Duyk et al. 1990/ Buckler et al. 1991 
b. Promoter trapping -
c. Poly A signal trapping -
III. Sequence-based 
a. Exon prediction Uberbacher and Mural 1991 
b. Species comparison/homology -
searches 
the genomic clone as a hybridisation probe. In this way, genes can be 
identified by hybridising DNA clones against Northern blots, cDNA 
libraries, zoo blots and Southern blots of genomic DNA digested with 
rare-cutter restriction endonucleases. 
4.1.3.1 The cDNA selection technique 
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In the case of identification of human genes, perhaps the biggest 
limitation is the abundance problem - some rare genes may be expressed 
at levels as low as 1 in 106 , making identification of these transcripts 
difficult and unlikely by conventional screening of a cloned cDNA library. 
For many of the techniques mentioned in Table 4.2, finding all the genes 
in even a single megabase of the human genome is labour intensive and 
technically complex; and some methods also suffer from being low in 
sensitivity. One strategy that may be used to avoid some of these 
problems is cDNA selection (also called direct selection, direct cDNA 
selection and hybrid selection; Lovett 1994). 
cDNA selection is a PCR-based hybridisation method developed to enrich 
for coding sequences. It is particularly useful in the positional cloning of 
loci associated with genetic disorders and for searching large genomic 
regions(> 2 Mb) for transcriptional units that are expressed at low levels. 
The concept underlying this technique is that a large genomic region or 
clone (e.g. YAC or cosmid) may be used to 'fish out' its cognate cDNAs 
from a starting mixture of cDNAs. Several rounds of hybridisation should 
lead to a huge enrichment of the desired cDNA sequences, enabling 
identification of the corresponding genes. Enrichments of approximately 
10 000 fold can be obtained after two rounds of selection when a region 
of about 1 Mb is targeted. In general, a third round of selection does not 
increase the yield substantially. 
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In this technique, the requirement for high quality starting cDNAs is very 
important, preferably derived from sources other than conventional 
cloned libraries. These libraries often contain contaminants and the 
representation of sequences may be skewed. Furthermore, when derived 
from complex tissues they are unlikely to contain cDNAs that represent 
rare transcripts. Most cDNA libraries consist of about 106 recombinant 
clones which is probably adequate sequence representation from 
transcripts expressed in one cell type. If the library is, however, derived 
from a complex tissue such as total brain and the transcript of interest is 
expressed at a low level in a sub-region of the brain, then 106 clones will 
probably not contain the cDNA of interest. It is therefore preferable to 
use complex sets of uncloned cDNAs that better represent the complexity 
of the starting mRNA. In addition, the choice of tissue or cell type from 
which to generate a set of cDNAs is an important first decision for this 
method. 
To efficiently identify new genes within selected cDNAs, it is crucial to 
either block or screen out common contaminants. In selections where 
YAC DNA is used as a target, ribosomal cDNA represents a major 
contaminant because YACs purified by PFGE are inevitably slightly 
contaminated with all the yeast chromosomes, including chromosome XII 
which carries > 100 copies of the yeast ribosomal locus. In addition, 
ribosomal RNAs are represented in most, if not all, libraries or pools of 
cDNAs, so in selections where ribosomal sequences are not pre-blocked, 
ribosomal cDNAs can comprise up to 70% of selected material. 
Fortunately, these sequences are easily blocked and/ or screened out 
after selection. The yeast 2µ plasmid is another DNA sequence that 
contaminates YAC preparations and can be avoided by pre-
electrophoresing YAC preparations before purification. Interme<:1-iate 
repetitive sequences such as the Alu repeats, can be blocked efficiently 
and are not usually a major problem. 
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One disadvantage with cDNA selection is that genes containing very 
short exons may be missed because the heteroduplexes formed with 
cognate cDNAs may not be sufficiently stable. A second problem is that 
cDNAs rnay hybridise to pseudogenes showing a high degree of homology 
to the cognate functional genes or to related members of a gene family. 
4.1.4 This study 
Following the mapping of the RPl 7 locus to chromosome 17q22, the 
positional cloning approach was attempted in an effort to identify the 
defective gene. An initial step in this approach involved the construction 
of a physical map for the 1 cM critical interval. A large scale sequencing 
effort on chromosome 17 is currently underway at the Center for Genome 
Research at the Whitehead Institute for Biomedical Research, USA 
(http:/ /www-genome.wi.mit.edu/) and this database was used as a 
starting point for the assembly of a contig spanning the RPl 7 locus. STS 
content mapping was used to identify overlapping YAC clones. 
The cDNA selection method was employed for the identification of gene 
transcription units in the RPl 7 YAC/BAC contig. This technique was 
chosen due to its relatively high success rate in other positional cloning 
projects and because it is amenable to the use of large genomic clones 
i.e. YACs. A foetal brain cDNA library was used in the selections since a 
suitable uncloned retina-specific cDNA library was unobtainable at the 
time. 
4.2 MATERIALS AND METHODS 
4.2.1 STS content mapping of YACs 
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The RP 1 7 physical map was constructed using YAC clones selected from 
the Whitehead/MIT genome Center physical map ofYAC contig WC 17.8 
(Hudson et al. 1995). For analysis of STS content, the seven CEPH mega 
YACs 913d6, 751c12, 948c8, 761e2, 961fl, 813b7 and 926c12 were 
streaked onto casein (Ura-, Trp-) media plates (Appendix C) and 
incubated at 30°C for two days. Single colonies of each YAC were 
screened directly using PCR by dipping a sterile toothpick into the colony 
and immediately mixing it into the PCR cocktail. The YACs were screened 
for the following nine STSs: D 17S 1604, D 17S792, D 17S923, D 17S 1855, 
CHLC.GATAllCll, CHLC.GATA6Gl0, D17S808, D17S948 and 
D17S794; and the three ESTs WI-6034, WI-6805 and FB10A2 
(purchased either from Research Genetics Inc., USA or GIBCO/BRL, 
USA). 
PCR conditions were 95°C for 5 min (to lyse the colonies and denature 
the DNA) followed by 35 cycles of 95°C for 30 sec, 55°C for 30 sec and 
72°C for 30 sec. A final extension step of 72°C for 5 min was also 
performed. The PCR reactions contained 5 pmol of each primer, 250 µM 
of each dNTP, 1.5 mM MgCb, 50 mM KCl, 10 mM Tris-HCl (pH 8.4), and 
0.5 U of Taq DNA polymerase (Perkin-Elmer Cetus, USA) in a total 
reaction volume of 10 µl. The PCR was performed on a Perkin-Elmer 
Thermal Cycler and the products were fractionated on 2% ethidium 
bromide-stained agarose gels. The presence or absence of a single PCR 
product of the appropriate size was tested at least twice. 
4.2.2 BAC library screening 
To cover a gap detected in the YAC contig, the Human Bacterial Artificial 
Chromosome DNA pools, Release III (Research Genetics Inc., USA) was 
investigated for the identification of clones positive for the markers WI-
6805 and CHLC.GATAl lCl 1. The BAC library is provided in a pooled 
format in 96-well microtitre plates and was screened according to the 
manufacturer's instructions. 
4.2.3 Isolation of BAC and YAC DNA 
Purified BAC and YAC DNA was required for the vectorette PCR and 
cDNA selection protocols, respectively. BAC DNA was isolated from the 
bacterial host genome using a standard alkaline lysis miniprep method 
as described in Sambrook et al. ( 1989). 
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YAC DNA from each clone was prepared in agarose plugs and subjected 
to pulsed-field gel electrophoresis in 1 % agarose gels (Appendix B). These 
gels were run in 0.5X TBE at 14°C. A contour-clamped homogeneous 
electric field (CHEF) apparatus (BIORAD-CHEF DR II System) was used 
and the running conditions used for each of the YACs are summarised in 
Table 4.3. After ethidium bromide staining for visualisation, the gels were 
Southern blotted onto Hybond N+ membranes (Amersham, USA) and 
hybridised with [a.32P]dCTP-labelled human COT-1 DNA in order to 
identify the YAC band. A Prep-A-Gene DNA isolation kit (BIORAD, USA) 
was used for the gel extraction of YAC DNA. The purification of YA Cs on 
PFGE is time-consuming but effectively eliminates the high background 
levels that result due to the presence of the total yeast genome. 
4.2.4 Vectorette PCR 
End probes of BACs were generated by the vectorette end fragment 
isolation method adapted from Riley et al. (1990). Briefly, the clone DNA 
was digested with a range of restriction enzymes (Alul, EcoRV, PvulI and 
RsaI) and ligated with the blunt-end vectorette cassette as described. 
These four vectorette libraries were used as templates and PCR was 
----------·- -~-- ~--~-~---
performed with a universal vectorette primer and either the SP6 or T7 
primers to amplify the terminal sequences. 
The oligonucleotides and primers used in this method are as follows: 
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Top strand blunt cassette 5'-AAg gAg Agg ACg CTg TCT gTC gAA ggT AAg 
gAA Cgg ACg AgA gAA ggg AgA g-3' 
Universal bottom strand cassette 5'-CTC TCC CTT CTC gAA TCg TAA 
CCg TTC gTA CgA gAA TCg CTg TCC TCT CCT T-3' 
Vectorette primer 5'-TCT CCC TTC TCg AAT CgT AAC CgT TCg TAC-3' 
T7 primer 5'-AAT ACg ACT CAC TAT Ag-3' 
SP6 primer 5'-gAT TTA ggT gAC ACT ATA g-3' 
4.2.5 cDNA selection 
The cDNA selection protocol was employed to isolate coding sequences in 
the newly constructed RP17 critical interval. Purified YAC 751c12 DNA 
was labelled with biotin using a Nick Translation Kit (Boehringer 
Mannheim, Germany) and hybridised to a pre-blocked foetal brain cDNA 
library (obtained from Dr. M. Lovett, UT Southwestern Medical Center, 
Dallas, USA). cDNA/YAC hybrids were captured using streptavidin 
coated magnetic beads (DYNAL, USA). Following the post-hybridisation 
washes, the primary selected cDNAs were subjected to a second round of 
selection. In order to monitor the level of enrichment obtained for the 
primary and secondary selected cDNAs, Southern blot analysis was 
performed using a reporter gene, the EST WI-6034, as a probe. The cDNA 
selection protocol is depicted in Fig. 4.2 and outlined in Appendix B. 
4.2.6 Cloning of secondary selected cDNA 
Secondary selected cDNAs were cloned into E-coli cloning vector pAMPlO 
using the CLONEAMP pAMPlO System [GIBCO/BRL, USA]. Ligation 
blocking DNA (eg COT-1, ribosomal 
and vector DNA) 
D D 
D D Cl 
starting cDNA library 






genomic contig DNA eg Y AC 









Capture on streptavidin-coated magnetic beads 
MAGNET>))))])] O
s s ,,,.s 8 8 
D~ 
s s-9 B 
Elute captured cDNAs 
t 
+ Amplify in PCR + Evaluate Selected· 
cDNA 
Figure 4.2 Flow diagram of the cDNA selection protocol using magnetic bead capture. 
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reactions were transformed into Library Efficiency DH5a. Competent Cells 
(GIBCO /BRL, USA) according to the recommended instructions and 
transformants were plated on Luria-Bertani agar (LA) containing 
Ampicillin (200 µg/ml) and grown at 37°C 0/N. 
Single colonies were picked and arrayed using sterile toothpicks, into five 
96-well microtitre plates containing Luria-Bertani broth (LB) with 200 
µg/ml Ampicillin. The plates were incubated at 37°C 0/N, after which LB 
containing 30% glycerol and 100 µg/ml Ampicillin was added. These five 
plates constitute the master set (maintained at -70°C), and a duplicate 
working copy of plates were made to prevent contamination. ·1 
4.2. 7 Evaluation of clones 
The lids of ten 96-well microtitre plates were filled with LA containing 
200 µg/ ml Ampicillin and overlaid with Hy bond N+ nylon membranes 
(Amersham, USA). A 96-well replica plater (robotic workstation) was used 
to stamp the arrayed clones from the five 96-well plates onto the 
membranes in duplicate in a high-density format. The lids were 
incubated at 37°C 0/N to allow the colonies to grow onto the filters. The 
following day, the filters were fixed in two solutions: 1.5 M NaCl/ 0.5 M 
NaOH and 1.5 M NaCl/ 0.5 M Tris-HCl (pH 7.4) at 65°C and pre-
hybridised with denatured herring sperm. One filter was probed with 
[a.32P]dCTP-labelled human COT-1 (GIBCO/BRL, USA) and a second filter 
was probed with yeast strain AB1380 DNA at 65°C 0/N. Following 
hybridisation, the blots were exposed to autoradiography at -70°C 0/N. 
4.2.8 Sequencing of cDNA inserts 
The plasmid DNA of ten colonies were isolated using a QIAprep Spin 
Miniprep Kit (QIAGEN, USA) according to the manufacturer's 
instructions. The cDNA inserts of these colonies were sequenced using 
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an ABI PRISM Dye Primer Cycle Sequencing Ready Reaction Kit (Perkin-
Elmer, USA). Sequencing reactions were performed with the M13 primer 
and AmpliTaq DNA Polymerase, FS and analysed by an ABI PRISM 377 
DNA Sequencer (Perkin-Elmer, USA). 
4.3 RESULTS 
4.3.1 Construction of a YAC/BAC contig for RP17 
To facilitate the identification of the RPl 7 adRP gene, an attempt was 
made to construct a YAC contig spanning the 1 cM critical interval 
between the markers Dl 7S1604 and Dl 7S948. A contig consisting of 
seven overlapping CEPH mega YACs was assembled according to their 
marker content, and the results are summarised in Fig. 4.3. 
STS content mapping revealed a gap in the YAC contig between markers 
WI-6805 and CHLC.GATAl lCl 1. In an effort to cover this gap, a BAC 
library was screened and two positive clones were identified: BAC 
100E23 (positive for WI-6805) and BAC 229L19 (positive for 
CHLC.GATAl lCl 1). Since each BAC was positive for one marker only, 
the vectorette PCR method was used to determine whether the inserts of 
the two BACs overlapped. An end-probe derived from the T7 terminus of 
BAC 100E23 was shown to hybridise to BAC 229Ll 9 (Fig. 4.4a). 
Similarly, an end-probe derived from the SP6 terminus of BAC 229Ll 9 
hybridised to BAC 100E23 (Fig. 4.4b). The specificity of these 
hybridisation experiments was verified by the observation that an SP6 
terminal sequence generated from BAC 1 OOE23 did not bind to BAC 
229Ll 9 (Fig. 4.4c). These findings indicate that the BAC vector arm 
sequences are not contributing to the hybridisation results and provide 
evidence which suggests that the two BAC inserts overlap. Therefore, 
assuming that none of the YACs have an internal deletion, continuous 
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Figure 4.3 Schematic diagram of a YAC/BAC contig constructed for the RP 17 critical interval. The bold upper line indicates the 







Figure 4.4 Dot blot analysis of the seven YACs and two BACs encompassing the 
RPl 7 contig, which were hybridised to end-probes generated from: 
(a) BAC 100E23 using primers 224 & T7; 
(b) BAC 229L 19 using primers 224 & SP6; 
( c) BAC 100E23 using primers 224 & SP6. 
Key to Figure 4.4 
1 = BAC 100E23 
3 = 913d6 
6 = 761e2 
11 = BAC 100E23 
2 = BAC 229Ll 9 
4 = 751cl2 
7 = 948c8 
5 = BAC 229Ll9 
8 = 961fl 9 = 813b7 10 = 926c12 
and overlapping clone coverage of the RPl 7 critical interval has been 
assembled. 
4 .3.2 YAC DNA isolation 
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High molecular weight DNA from each of the seven Y AC clones were 
prepared in agarose blocks and subjected to pulsed-field gel 
electrophoresis in order to separate the YAC DNA from the yeast host 
chromosomes. Southern blot analysis was performed to identify the YAC 
band on the pulsed-field gel and the YAC DNA was subsequently gel-
purified for use in subsequent gene identification experiments. 
4.3.3 cDNA selection 
The cDNA selection protocol was employed in order to search for 
candidate genes residing in the RPl 7 critical interval. After two rounds of 
selection using YAC 75 lc12, significant enrichment of the reporter gene 
(WI-6034) was obtained which indicates that the selections had been 
successful (Fig. 4.5). The secondary selected cDNAs were cloned into the 
E-coli cloning vector pAMPlO and a total of 480 transformants were 
selected and patched onto five 96-well microtitre plates. 
In order to evaluate the clones, the colonies were probed with human 
COT-1 DNA and yeast strain AB1380 total DNA to eliminate or screen 
out contaminating repetitive DNA elements and yeast sequences. The 
hybridisation experiments to COT-1 DNA revealed 32 out of 480 (i.e. 7%) 
positive colonies (data not shown). This figure correlates well with the 
roughly 10% of colonies routinely found to contain repetitive sequences 
in most cD NA selection experiments (Lovett 1994). None of the colonies 
hybridised to the yeast AB1380 probe (data not shown) which may 
indicate that there were no contaminating yeast DNA present in the 
selected clones. The plasmid DNA of ten randomly chosen clones were 
1 2 3 4 5 6 7 
... 
Figure 4.5 A Southern blot of the cDNA selections using YAC 751c12, 
which was probed with the reporter gene WI-6034. 
Lanes 1, 2 & 3 contain 1, 0.2 & 0.1 ng of starting cDNA, 
respectively; lane 4 contains 2 µl of 1 ° selected cDNA and 




sequenced and subjected to BLASTN analysis (Table 4.4). Two of the 
selected cDNAs were highly homologous to the human putative cerebral 
cortex transcriptional regulator T-Brain-1 mRNA and another two 
exhibited significant similarity to human 18S ribosomal RNA. The 
presence of ribosomal sequences may be due either to ribosomal genes 
residing on YAC 751c12 or to contamination with yeast chromosome XII 
which carries the yeast ribosomal locus. A further: two clones exhibited 
homology to the chromosome 17-specific clones hRPC.18_F_17 and 
hCIT.9l_J_ 4 thereby implying that the selections were specific for the 
correct chromosome. One of the selected mRNAs is part of the 
chromosome 16 Pl clone 94-lOH, which indicates that the YAC 75lc12 
may be chimaeric. This observation should be confirmed with FISH 
experiments using this YAC as a probe. Another two of the selected 
mRNAs exhibited weak similarity to the Homo sapiens retroviral-like 
sequence S7 l. The last clone to be sequenced contained only a 23 bp 
insert that, upon inspection, proved to be the linker oligonucleotide 
which had been attached to the starting pool of cDNAs as a priming site 
for PCR. It is imperative that the prevalence of this contaminant in the 
selected material be assessed and screened out. This sequence cannot, 
however, be screened by hybridisation experiments since all the cloned 
cDNAs contain this oligonucleotide and further investigations to resolve 
this problem are necessary. 
4.4 DISCUSSION 
A physical map has been constructed that encompasses the adRP locus 
on 1 7 q22. Evidence is provided which indicates that an overlapping array 
comprising of seven mega YACs and two BACs has been assembled 
spanning the critical region. This YAC/BAC contig also contains the 
respective adRP-flanking recombinant markers {Dl 7S1604 and 
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Table 4.4 Sequencing results often secondary selected cDNAs. 
Clone Insert length Homologous to: BLASTN 
(hp) e value 
1 416 Human putative cerebral cortex e-171 
transcriptional regulator 
2 162 Homo sapiens retroviral-like sequence S71 0.002 
3 424 Human putative cerebral cortex 4e-77 
transcriptional regulator 
4 411 Homo sapiens chromosome 16, Pl clone 0.0 
5 485 Homo sapiens chromosome 17 clone Se-74 
6 380 Homo sapiens chromosome 17 clone e-171 
7 232 Human 18S ribosomal RNA 2e-99 
8 162 Homo sapiens retroviral-like sequence S71 0.002 
9 232 Human 18S ribosomal RNA Se-97 
10 23 Linker sequence only 0.0 
D 17S948) thereby ensuring that the RPl 7 gene is present. The high 
density of PCR-based genetic markers currently available in this region, 
which allows for contig assembly without the need for extensive YAC 
walking or restriction mapping to establish overlaps, facilitated the 
construction of this map. 
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Refined localisation of the RP 17 critical region by both genetic and 
physical mapping provides the next step towards the eventual 
identification of the adRP gene. The YAC/BAC contig described here lays 
the groundwork for the construction of a transcriptional map for this 1 
cM interval. A gene map should facilitate the identification of the adRP 
gene and also provide candidate genes for other genetic disorders that 
map to this region of chromosome 17 q22. 
There is an excess of genes on chromosomes 1, 1 7 and 19, based on a 
comparison of the number of mapped ESTs to the cytogenetic lengths of 
the various chromosomes (Schuler et al. 1996). Genes that are known to 
map to the RPl 7 critical interval include the three ESTs used in the 
physical mapping viz. WI-6034, WI-6805 and FB10A2. WI-6034 is the 
p70 ribosomal protein S6 kinase and is expressed in eye, foreskin, lung, 
placenta and testis; and WI-6805 is an unidentified transcript found in 
adrenal gland, brain, lung and uterus. FB10A2 is another unidentified 
transcript, which had been isolated from a foetal brain cDNA library. 
According to the Human Gene Map database 
(http://www.ncbi.nlm.nih.gov/cgi-bin/SCIENCE96/) from the National 
Center for Biotechnology Information, other genes residing in the region 
of the RPl 7 contig include the T-box 2 gene, human platelet endothelial 
cell adhesion molecule, p80-coilin and myeloperoxidase precursor. None 
of these genes, however, is a strong candidate at this stage. 
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Tremendous time and effort are required to complete a positional cloning 
project successfully. This implies that the candidate gene isolation 
techniques used must be both rapid and thorough. In the present study, 
the cDNA selection technique was applied to a YAC from the RPl 7 contig. 
This novel approach was utilised because the cDNA selection protocol is 
less labour-intensive and less technically demanding than many of the 
other gene identification methods currently available. Two rounds of 
selection were performed and ten clones were sequenced in order to 
monitor the success of the method. The presence of a 23 bp contaminant 
was detected in one of the clones sequenced. As the cDNA selection 
method is PCR-based, it is likely that the cloning of this short 
oligonucleotide may be due to a sequence and length bias of the PCR 
technique. Usually shorter fragments tend to be selected at each 
successive round of selection at the expense of the longer sequences. 
Future prospects for this project include the further evaluation of the 
secondary selected material as well as the screening out of contaminants 
e.g. the 18S ribosomal mRNA and the linker oligonucleotide (Table 4.4). 
Additional cDNA selections should also be performed using an uncloned 
retina-specific pool of cDNAs, rather than a conventional commercially-
available library. The construction of a high-quality retina cDNA library 
would be a valuable resource for the cloning of genes underlying various 
retinal degenerative disorders. It is also imperative that FISH analysis be 
performed on the YACs and BACs comprising the RPl 7 contig in order to 
determine if any of the clones are chimaeric. This information would 
prove useful when interpreting results obtained from cDNA selection 
experiments. 
In conclusion, in order to increase the chances of identifying the RPl 7 
gene, a number of positional cloning techniques need to be employed 
simultaneously. In one study, the cloning of the breast cancer 
susceptibility gene BRCAl was achieved by a combination of three 
methods: (i) hybrid selection (ii) direct screening of cDNA libraries and 
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(iii) random sequencing (Harshman et al. 1995). This group found that by 
using a range of gene isolation techniques they identified a large number 
of candidate gene fragments, which subsequently facilitated the isolation 
of the causative gene. 
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SCREENING OF POSITIONAL CANDIDATE GENES 
FOR RP17 
Summary: 
Four positional candidate genes for the RPl 7 locus viz. 
gamma subunit of phosphodiesterase (PDEG), tissue 
inhibitor of metallo~roteinases-2 (TIMP2), protein kinase C 
alpha (PKCA) and retinal fascin, were examined in the two 
RPl 7-linked families. Recombination events between the 
adRP locus and (i) single-stranded conformation 
polymorphisms in PDEG and retinal fascin; and (ii) a 
restriction fragment length polymorphism in TIMP2 
provided evidence for the exclusion of these three 
candidate genes. The PKCA gene was excluded on the basis 
of physical map data. Also, 1727 bp of the 2245 bp PKCA 
cDNA was sequenced and no mutations detected. In 
addition, direct DNA sequencing revealed three novel 
polymorphisms in the retinal fascin gene. 
5.1 INTRODUCTION 
5.1.1 The positional candidate gene approach 
The choice of strategy used to identify genes causative of inherited 
disorders depends on what is known about the pathogenesis of the 
condition and what resources are available i.e. animal models, clone 
libraries, chromosomal abnormalities etc. Ultimately, several of these 
strategies generate candidate genes which are then investigated 
individually for any evidence that implicates them as the defective gene. 
For the positional candidate gene approach, once a disorder has been 
mapped to a specific sub-chromosomal localisation, database searches 
can be made to identify candidate genes; and with more and more 
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human genes being mapped to specific chromosomal regions, this 
approach is set to dominate the field. Some of the notable successes of 
inherited disease genes identified by positional candidate methods are 
the fibrillin gene for Marfan syndrome {Peltonen and Kainulainen 1992), 
paired box gene PAX3 for Waardenburg syndrome type 1 {Baldwin et al. 
1992) and P-Amyloid precursor for Alzheimer disease (Goate et al. 1991). 
In addition, with this method both rhodopsin and peripherin/ RDS were 
successfully identified as adRP genes (Dryja et al. 1990, Farrar et al. 
1991, Kajiwara et al. 1991). 
Once a disorder has been localised, a few selection criteria may be used 
to choose potential candidate genes for further screening: 
• The candidate gene might exhibit the appropriate expression pattern or 
function. 
For some disorders, observations on the pathogenesis may 
immediately suggest candidate genes with an appropriate expression 
pattern or function e.g. for RP, potential candidates are genes 
expressed in the photoreceptors or genes coding for components of 
the phototransduction pathway etc. 
• The candidate gene might show homology to a gene implicated in an 
animal model of the disorder. 
If an animal phenotype shows a striking similarity to a human 
disorder, it may result from mutations in the animal ortholog of the 
human disease-causing gene. In cases where the human gene is 
unknown, knowledge of the animal ortholog could be used to help 
identify and characterise the human gene. Such an animal model may 
have originated spontaneously or have been created artificially by X-
rays, chemical mutagenesis or even by a gene targeting approach. 
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• The candidate gene might show homology or functional relatedness to 
a gene implicated in a similar human disease phenotype. 
If a gene shown to be responsible for a particular condition is a 
member of a multigene family, then other members of the family 
would be candidates for phenotypically similar disorders. A candidate 
gene may also be suggested on the basis of a close functional 
relationship to a known disease-causing gene i.e. both genes are part 
of the same metabolic or developmental pathway. 
5.1.2 Introductory background to candidate genes for RPI 7 
Using the above selection criteria, four candidate genes were investigated 
for their possible involvement in the pathogenesis of adRP in families 
RPD8 and RPD 19. The positional candidates chosen for study were: 
i) Gamma subunit of phosphodiesterase, 
ii) Tissue inhibitor of metalloproteinases-2, 
iii) Protein kinase C alpha and 
iv) Retinal fascin. 
5.1.2.1 Gamma subunit of rod phosphodiesterase (PDEG) 
cGMP-phosphodiesterase (PDE) is a key component of the 
phototransduction pathway in retinal rod cells and is composed of alpha, 
beta and two identical gamma subunits (Farber 1995). The alpha and 
beta subunits together contain the catalytic site involved in the 
hydrolysis of cyclic GMP to 5' GMP and the enzyme becomes active only 
when the gamma subunits are removed by activated transducin (refer to 
phototransduction cascade, Section 1.1.3). 
In 1990, a 1012 bp human cDNA encoding the gamma subunit of PDE 
(PDEG; MIM 180073) was cloned and sequenced (Tuteja et al. 1990). The 
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coding region of 261 bp was found to be highly homologous to the 
corresponding cDNAs from bovine and mouse retinas; and a comparison 
of the deduced amino acid sequences of the proteins indicated that this 
gene has been well conserved through evolution (97.7% identity between 
human and bovine; and 96.6% identity between human and mouse). The 
human PDEG gene was originally assigned to chromosome 17q2 l. l using 
in situ hybridisation techniques (Tuteja et al. 1990). It was subsequently 
mapped to a more distal location on 1 7 q25 by a combination of in situ 
hybridisation and genetic linkage analysis (Dollfus et al. 1993). 
Mutations in genes encoding the alpha (PDEA) and beta (PDEB) subunits 
of PDE have been implicated in various hereditary retinal degenerations. 
Pathogenic point mutations in PDEA have been associated with arRP in 
two pedigrees (Huang et al. 1995). Mutations in PDEB have been shown 
to co-segregate with some forms of arRP (McLaughlin et al. 1993) and in 
one family with autosomal dominant congenital stationary night 
blindness (Gal et al. 1994). 
To date, the PDEG gene has not been associated with any human retinal 
degeneration. A cloned fragment of the gene was used as a probe to 
search for submicroscopic deletions or rearrangements of PDEG in 
patients with RP and Usher syndrome type 1, but no altered size or 
homozygous deletions were detected ( Cotran et al. 1991). In another 
study, an extensive screen was undertaken using SSCP analysis of the 
coding region of PDEG in 704 unrelated patients with RP or allied 
disorders (Hahn et al. 1994). No pathogenic mutations were revealed, 
however, two frequent polymorphisms were detected in the 5' and 3' 
untranslated regions of the gene. Disruption of the mouse PDEG gene 
using a gene targeting approach resulted in a rapid retinal degeneration 
resembling human RP (Tsang et al. 1996). This finding indicates that the 
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inhibitory gamma subunits appear to be essential for the integrity of the 
photoreceptors and the expression of PDE activity in vivo. 
PDEG was thought to be a likely candidate for the RPI 7 locus on the 
basis of its chromosomal location, photoreceptor-specific expression 
pattern and known involvement in the rod phototransduction cascade. 
The possible association of this gene with adRP in the two 17q-linked 
adRP families was therefore investigated in this study. 
5.1.2.2 Tissue inhibitor of metalloproteinases-2 (TIMP2) 
1 
The matrix metalloproteinases are a family of enzymes involved in the 
degradation of components of the extracellular matrix. The unrestrained 
activity of these enzymes may result in extensive tissue damage and they 
have been implicated in several different pathological conditions, 
including tumour cell invasion and rheumatoid arthritis (Matrisian 
1990). The natural inhibitors of metalloproteinases are the tissue 
inhibitors of metalloproteinases (TIMP) protein family, and individual 
members of this family may possess selective affinities for different 
matrix metalloproteinases (Matrisian 1990). 
TIMP3, a member of the TIMP gene family, has been shown to be 
causative of Sorsby fundus dystrophy (Weber et al. 1994). This rare type 
of retinal degeneration manifests with loss of central vision due to 
macular degeneration and progressive atrophy of the retina and choroid. 
Furthermore, increased expression of TIMP3 mRNA has been reported in 
retinas from two individuals with simplex RP (Jomary et al. 1995). 
TIMP2, identified in 1989 (Stetler-Stevenson et al. 1989), has been 
mapped to 17q25 by analysis of somatic cell hybrids and fluorescent in 
situ hybridisation (De Clerck et al. 1992). This gene comprises 5 exons 
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and the complete genomic nucleotide sequence spans 83 kb (Hammani et 
al. 1996). 
Although not previously associated with retinal dystrophies, TIMP2 (MIM 
188825) was investigated as a positional candidate for RPl 7 in family 
RPD8. An intragenic restriction fragment length polymorphism (RFLP) 
was used as a marker for linkage studies in the adRP kindred. 
5.1.2.3 Protein kinase C alpha (PKCA) 
Protein kinase C alpha (PKCA, MIM 176960) is a candidate for the RPl 7 
locus because a photoreceptor-specific protein kinase C was shown to be 
required for the deactivation and rapid desensitisation of the 
phototransduction cascade in Drosophila (Schaeffer et al. 1989; Smith et 
al. 1991). In addition, PKC has been shown to be involved in the in vitro 
phosphorylation of rhodopsin in the outer segments of rod cells (Newton 
and Williams 1993). 
Three members of the PKC gene family viz. PKC alpha (PKCA), PKC beta 
(PKCB) and PKC gamma (PKCG) are highly homologous to each other 
(Coussens et al. 1986). A mutation in PKCG has been shown to segregate 
with RP in two families linked to the adRP locus on 19q (Al-Maghtheh et 
al. 1998). This change (Arg659Ser) may, however, be a rare 
polymorphism since no pathogenic mutations were detected in three 
other 19q-linked kindreds. PKCA was originally isolated from bovine 
brain (Parker et al. 1986) and the human homologue has been assigned 
to human chromosome 17 q22-24 using in situ hybridisation (Coussens 
et al. 1986). Subsequently, a high-resolution radiation hybrid map was 
used to refine the position of PKCA relative to microsatellite markers on 
1 7 q22 (Foster et al. 1996). 
The involvement of the PKCA gene in adRP in family RPD8 was 
investigated using three intragenic RFLPs, as well as sequencing of the 
cDNA in a RP affected family member. In addition, the presence of a 
PKCA-specific expressed sequence tag (EST) was screened for in the 
RPl 7 critical interval. 
5.1.2.4 Retinal fascin 
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Fascins are an evolutionarily conserved family of proteins that organise 
filamentous actin into bundles (Edwards and Bryan 1995). Due to their 
wide distribution, they are thought to play important roles in the 
morphogenesis of diverse intracellular structures. Mutations in the 
Drosophila homologue, the singed gene product, result in malformed 
bristles and sterile females (Edwards and Bryan 1995). 
The recently identified retinalfascin gene, isolated from a bovine retina 
cDNA library, was shown to be retina-specific and expressed exclusively 
in the inner segment of photoreceptor cells (Saishin et al. 1997). 
Sequence analysis of the deduced protein indicates that it has 55% 
amino acid identity with murine fascin, 57% with human fascin and 52% 
with that of Xenopus fascin, thereby providing evidence that retinal 
fascin is a novel member of the fascin gene family. The exact function of 
retinalfascin is unknown, but it is thought to play a role in 
photoreceptor cell-specific events, such as disc morphogenesis (Saishin 
et al. 1997). The gene was recently mapped to chromosome 17q by 
fluorescent in situ hybridisation analysis (B. Tubb, personal 
communication) 
Retinal f ascin was examined as a candidate for RP 1 7 on the basis of both 
its localisation to chromosome 17q and its photoreceptor cell-specific 
expression pattern. 
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5.2 MATERIALS AND METHODS 
5.2.1 Single strand conformation polymorphism (SSCP) 
analysis of PDEG 
Two intragenic polymorphisms have been reported in the 5' and 3' 
untranslated regions (UTRs) of the PDEGgene (Hahn et al. 1994). One 
polymorphism is the deletion of a cytosine in the 5' UTR 14 bp upstream 
of the initiation codon. The allele frequencies are calculated to be 0.11 
and 0.89 based on 112 individuals of mixed North American ancestry. 
The second polymorphism is an Al447G transversion in the 3'. UTR 45 
bp after the termination codon, with allele frequencies 0.36 and 0.64. In 
order to ascertain whether the PDEG gene segregates with the' adRP 
disease phenotype, the two SSCP-detectable polymorphisms were 
analysed in families RPD8 and RPD 19 using standard SSCP techniques 
(Appendix B, Orita et al. 1989). 
The following primer sets were used: 
for the 5' polymorphism, forward: 5'-TgC ACT TgA CCg CAg CAg gA-3', 
reverse: 5'-CCC ATC CCC CAg CTC TgC TT-3'; 
and for the 3' polymorphism, forward: 5'-CTC TgA TCC gTg gCC CgT TT-
3', reverse: 5'-CTC AAC Agg AAT CCT gAg CA-3'. 
PCR conditions were as described in Chapter 3 except the [a.32P]dCTP 
was omitted from the PCR reaction and the PCR products were detected 
by the silver-staining technique (Appendix B). 
Two point lod scores were calculated using the MLINK option of the 
LINKAGE package of programs (Version 5.1; Lathrop et al. 1984). The 
penetrance was set at 100% with a gene frequency of 0.0001. 
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5.2.2 Restriction fragment length polymorphism (RFLP) 
analysis of TIMP2 
A Taql RFLP in the TIMP2 gene has previously been reported with 
polymorphic bands at 3.0 kb and 1.0 kb, and three additional constant 
bands at 2.5 kb, 1.4 kb, and 0.9 kb (Jares et al. 1994). The frequencies 
of the 3.0 kb and 1.0 kb alleles, as calculated in Caucasian individuals, 
are 0.76 and 0.24, respectively, with an observed heterozygosity of 0.28 
(Jares et al. 1994). 
The Taql RFLP was genotyped in family RPD8 using Southern blot 
hybridisation and a 791 bp EcoRI-XbaI fragment of TIMP2 cDNA 
(provided by WG Stetler-Stevenson, NIH, USA; Stetler-Stevenson et al. 
1990) as a probe. Southern blots were prepared, according to protocols 
in Appendix B, from TaqI-digested genomic DNA (Vandenplas et al. 
1984). The membranes were_ hybridised overnight at 65°C with the 
[a32P]dCTP-labelled probe (Appendix B), washed at a final stringency of 
0.6X SSC; 0.3% SDS at 65°C and exposed to Agfa Curix X-ray film at · 
-70°C for one week. Using this two-allele ·polymorphism, each family 
member tested could be assigned a [1/ 1], [1/2] or [2/2] genotype. 
Two point lod scores were calculated, as described in Section 5.2.1, 
between the adRP locus and the Taql RFLP in the TIMP2 gene. 
5.2.3 Investigation of PKCA 
i) RFLP analysis 
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Three RFLPs in the PKCA gene have been reported and are detected with 
the restriction enzymes: Rsal, KpnI and Dral (Summar et al. 1989). 
Polymorphic bands are detected with Rsal at 4.3 kb and 2.5 kb; with 
KpnI at 6.8 kb and 5. 7 kb and with Dral at 2.6 kb and 1.6 kb. All three 
RFLPs were genotyped in family RPD8 using Southern blot hybridisation 
and a 1.29 kb fragment of PKCA cDNA from plasmid phPKC-alpha7 
(American Type Culture Collection, USA) as a probe. The plasmid, 
obtained as a stab culture in E-coli, was purified according to 'standard 
protocols (Sambrook et al. 1989) and digested with EcoRI at 37°C 
overnight, to excise the insert. Southern blots were prepared from 
genomic DNA digested with the appropriate restriction enzyme and 
subsequently hybridised, overnight, with [a.32P]dCTP-labelled probe 
(Appendix B). After the post-hybridisation washes, the blots were exposed 
to autoradiography, overnight. 
ii) Sequencing of PKCA cDNA 
In order to screen for pathogenic mutations in the PKCA gene, seven sets 
of primers (Table 5.1) were designed to amplify and sequence the 2245 
bp of PKCA cDNA (Finkenzeller et al. 1990; EMBL accession number 
X52479). The primers A to E were originally designed to amplify the 
PKCA cDNA in five overlapping fragments of approximately 500 bp each 
(Fig. 5.1), however, primers A, D and E either did not produce a PCR 
product (set A) or multiple non-specific PCR products were evident (sets 
D and E). In order to resolve these problems, primers F and G (Fig. 5.1) 
which amplify the first 985 bp of the 5' end and the last 945 bp of the 3' 
end of the cDNA, respectively were used (Alvaro et al. 1993). 
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Total RNAwas extracted from Epstein-Barr virus-transformed 
lymphoblasts (Appendix B) of both an adRP affected member and an 
unaffected member from family RPD8 by a method derived from 
Chomczynski and Sacchi (1987). The RNA was reverse transcribed with a 
reverse transcriptase and PKCA cDNA was amplified by .PCR and directly 
sequenced in order to screen for potentially pathogenic mutations 
(Appendix B). 
iii) Screening for PKCA 5' UTR expressed sequence tag 
Primers were designed which amplify a 3'UTR expressed sequence tag 
(EST) specific for the PKCA gene (Fig. 5.1). The sequences are as follows: 
forward, 5'-AgT ggA AgT gAA TCC TTA AC-3', reverse, 5'-CTT CCA CTA 
AGA TAA TgT TC-3'. 
The seven YACs and two BACs spanning the RPI 7 critical interval 
(Chapter 4) were screened for the presence of the PKCA EST by PCR. The 
reactions were performed with approximately 20 ng ofYAC or BAC DNA 
in 10 µl reaction volumes containing 1.5 mM MgCh, 50 mM KCl and 10 
mM Tris-HCI (pH 8.4), 250 µM of each dNTP, 10 pmol of each primer and 
0.5 U of Taq DNA polymerase (GIBC_Q/BRL, USA). The PCR reactions 
were amplified at 94°C for 3 min, 30 cycles of 94°C for 30 sec, 55°C for 
30 sec, 72°C for 1 min, with a final extension of 72°C for 5 min on an 
Omnigene Thermal Cycler (Hybaid, USA). PCR products were visualised 
on ethidium bromide-stained 1 % agarose gels. The clones from which the 
EST primers amplified either an appropriately sized product or no 
product were recorded as positive or negative, respectively. 
Table 5.1 List of primers used to sequence PKCA cDNA. 
Primer Set Annealing Forward 
temperature 
Set A - 5 '-ggA gCA AgA ggT ggT Tgg gg-3' 
SetB ss 0c 5'-Tgg gTC ACT gCT CTA Tgg AC-3' 
SetC ss 0 c 5'-ggA gTT TCg gAg CTg ATg AA-3' 
SetD 60°C 5' -TgA TgA CgT ggA gTg CAC CA-3' 
SetE 60°C 5'-CTA Tgg CgT CCT gTT gTA Tg-3' 
SetF ss0 c 5' -ggA gCA AgA ggT ggT Tgg-3' 
SetG 60°C 5'-gAC CTC ATg TAC CAC ATT CA-3' 
Reverse 
5'-CTC AgT gTg ATC CAT TCC gC-3' 
5'-gCC AAg TTT ggC TTT CTC gA-3' 
5'-ggT CCC CAC CgT TgA CAT AT-3' 
5'-CgT TgT gCT CCA TgA TAg AC-3' 





primer Ffor/ primer Afor 
1 GGAGCAAGAG GTGGTTGG/GG GGGGACCATG GCTGACGTTT TCCCGGGCAA 
51 CGACTCCACG GCGTCTCAGG ACGTGGCCAA CCGCTTCGCC CGCAAAGGGG 
101 CGCTGAGGCA GAAGAACGTG CACGAGGTGA AGGACCACAA ATTCATCGCG 
151 CGCTTCTTCA AGCAGCCCAC CTTCTGCAGC CACTGCACCG ACTTCATCTG 
201 GGGGTTTGGG AAACAAGGCT TCCAGTGCCA AGTTTGCTGT TTTGTGGTCC 
251 ACAAGAGGTG CCATGAATTT GTTACTTTTT CTTGTCCGGG TGCGGATAAG 
301 GGACCCGACA CTGATGACCC CAGGAGCAAG CACAAGTTCA AAATCCACAC 
primer Bfor 
351 TTACGGAAGC CCCACCTTCT GCGATCACTG TGGGTCACTG CTCTATGGAC 
401 TTATCCATCA AGGGATGAAA TGTGACACCT GCGATATGAA CGTTCACAAG 
451 CAATGCGTCA TCAATGTCCC CAGCCTCTGC GGAATGGATC ACACTGAGAA 
primer Arev 
501 GAGGGGGCGG ATTTACCTAA AGGCTGAGGT TGCTGATGAA AAGCTCCATG 
551 TCACAGTACG AGATGCAAAA AATCTAATCC CTATGGATCC AAACGGGCTT 
601 TCAGATCCTT ATGTGAAGCT GAAACTTATT CCTGATCCCA AGAATGAAAG 
651 CAAGCAAAAA ACCAAAACCA TCCGCTCCAC ACTAAATCCG CAGTGGAATG 
701 AGTCCTTTAC ATTCAAATTG AAACCTTCAG ACAAAGACCG ACGACTGTCT 
751 GTAGAAATCT GGGACTGGGA TCGAACAACA AGGAATGACT TCATGGGATC 
primer Cfor 
80 1 CCTTTCCTTT GGAGTTTCGG AGCTGATGAA GATGCCGGCC AGTGGATGGT 
851 ACAAGTTGCT TAACCAAGAA GAAGGTGAGT ACTACAACGT ACCCATTCCG 
90 1 GAAGGGGACG AGGAAGGAAA CATGGAACTC AGGCAGAAAT TCGAGAAAGC 
primer Brev 
951 CAAACTTGGC CCTGCTGGCA ACAAAGTCAT CAGTCCCTCT GAAGACAGGA 
primer Frev 
1001 AACAACCTTC CAACAACCTT GACCGAGTGA AACTCACGGA CTTCAATTTC 
1051 CTCATGGTGT TGGGAAAGGG GAGTTTTGGA AAGGTGATGC TTGCCGACAG 
1101 GAAGGGCACA GAAGAACTGT ATGCAATCAA AATCCTGAAG AAGGATGTGG 
primer Dfor 
1151 TGATTCAGGA TGATGACGTG GAGTGCACCA TGGTAGAAAA GCGAGTCTTG 
1201 GCCCTGCTTG ACAAACCCCC GTTCTTGACG CAGCTGCACT CCTGCTTCCA 
Fig. 5 .1 continued overleaf 
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1251 GACAGTGGAT CGGCTGTACT TCGTCATGGA ATATGTCAAC GGTGGG/GACC 
primer G:Eor primer Crev 
1301 TCATGTACCA CATTCAGCAA GTAGGAAAAT TTAAGGAACC ACAAGCAGTA 
1351 TTCTATGCGG CAGAGATTTC CATCGGATTG TTCTTTCTTC ATAAAAGAGG 
1401 AATCATTTAT AGGGATCTGA AGTTAGATAA CGTCATGTTG GATTCAGAAG 
1451 GACATATCAA AATTGCTGAC TTTGGGATGT GCAAGGAACA CATGATGGAT 
1501 GGAGTCACGA CCAGGACCTT CTGTGGGACT CCAGATTATA TCGCCCCAGA 
1551 GATAATCGCT TATCAGCCGT ATGGAAAATC TGTGGACTGG TGGGCCTATG 
primer E:Eor 
1601 GCGTCCTGTT GTATGAAATG CTTGCCGGGC AGCCTCCATT TGATGGTGAA 
1651 GATGAAGACG AGCTATTTCA GTCTATCATG GAGCACAACG TTTCCTATCC 
primer Drev 
1701 AAAATCCTTG TCCAAGGAGG CTGTTTCTAT CTGCAAAGGA CTGATGACCA 
1751 AACACCCAGC CAAGCGGCTG GGCTGTGGGC CTGAGGGGGA GAGGGACGTG 
1801 AGAGAGCATG CCTTCTTCCG GAGGATCGAG TGGGAAAAAC TGGAGAACAG 
1851 GGAGATCCAG CCACCATTCA AGCCCAAAGT GTGTGGCAAA GGAGCAGAGA 
1901 ACTTTGACAA GTTCTTCACA CGAGGACAGC CCGTCTTAAC ACCACCTGAT 
1951 CAGCTGGTTA TTGCTAACAT AGACCAGTCT GATTTTGAAG GGTTCTCGTA 
2001 TGTCAACCCC CAGTTTGTGC ACCCCATCTT ACAGAGTGCA GTATGAAACT 
2051 CACCAGCGAG AACAAACACC TCCCCAGCCC CCAGCCCTCC CCGCAGTGGA 
EST primer:Eor primer Erev 
2101 AGTGAATCCT/TAACCCTAAA ATTTTAAGGC CACGGCTTGT GTCTGATTCC 
2151 GGAGGCCTGA AAATTGTAGG GTTATTAGTC CAAATGTGAT CAACTGGGTC 
2201 TCTCTCTTAC AACCAAGAAC ATTATCTTAG TGGAAG 
primer Grev/ EST primerrev 
Figure 5.1 cDNA sequence of the protein kinase C alpha gene (length 2245 bp; 
Genome Database accession number X52479). The relative positions of 
the various primers used to amplify the gene are depicted in blue. 
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5.2.4 DNA sequencing and SSCP analysis of retinal fascin 
i) Direct DNA sequencing 
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The 5 exons and the putative promoter region of the retinal fascin gene 
were PCR amplified in an affected and an unaffected family member from 
each of the two adRP families. The 11 pairs of primers that were used to 
amplify the exons are listed in Table 5.2 (B. Tubb, personal 
communication). Due to their large size, the promoter region and exon 1 
were amplified in two and five overlapping fragments, respectively. PCR 
products were purified in QIAquick spin columns (Qiagen, Germany) 
according to the manufacturers' instructions and sequenced with a Taq 
Dideoxy Terminator Cycle sequencing kit (Perkin Elmer, USA)i The 
sequencing reactions were separated by automated capillary 
electrophoresis in an ABI PRISM 310 Genetic Analyzer (Perkin Elmer, 
USA). For confirmation of results, DNA sequencing was performed on 
both stands. 
ii) SSCP analysis 
Direct DNA sequencing revealed three novel intragenic polymorphisms in 
retinalfascin: two in the 5' putative promoter region and one in exon 1. 
All three polymorphisms were genotyped in families RPD8 and RPD 19 
using standard SSCP techniques in order to determine whether an allele 
of retinalfascin segregates with the disease phenotype. 
Allele frequencies of the three polymorphisms were calculated in 88 
chromosomes obtained from individuals of diverse ethnic origin. 
The frequencies observed for the two 5' polymorphisms are: 
0.84 and 0.16 for an A to G transversion located 707 bp upstream of the 
initiation codon; and 0.96 and 0.04 for a C to G transition located 622 bp 
upstream of the initiation codon. Both polymorphisms were amplified 
Table 5.2 List of primers used to sequence the promoter and coding regions of the retinal fascin gene. 
Region I Forward primer Reverse primer 
of gene 
,romoter I 5'-gAC gTC gAC Agg CTg CAC ggC CAC TgT gT-3' 5'-TgA TCC CCTTTTCCTCAT AgC-3' 
romoter 5'-CCA CTg f!AC ggC TIC TAC AT-3' 5'-CCCA 
exon 1 5'-TAA 
exon 1 
exon 1 A-3' 
exon 1 -3' 
exon 1 5'-CCAC 
exon2 




and detected in a single PCR product using the following primers, 
forward 5'-gAC gTC gAC Agg CTg CAC ggC CAC TgT gT-3', 
and reverse 5'-TgA TCC CCT TTT CCT CAT AgC-3'. 
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The polymorphism in exon 1 is a T to C transition positioned 738 bp 3' of 
the initiation codon. The PCR primers used to amplify this polymorphism 
are: forward 5'-gCA TgA ATT CgA gCC gAC ggT ACT gCC TCA AgT CC-3' 
and reverse 5'-CgT AgT CgA CCT TgC CgC ACA gAg ACg TAg Cgg Tg-3'. 
Two point lod scores were calculated, as described previously, for the 
intragenic polymorphism in retinalfascin versus the adRP phenotype in 
the two 17q-linked families. 
5.3 RESULTS 
5.3.1 Exclusion of PDEG 
An Al447G polymorphism in the 3' UTR of PDEGwas genotyped in 
family RPD8 (Fig. 5.2a) and proved to be informative in this family. The 
segregation of alleles in the pedigree are presented in Fig. 5.2b. This 
polymorphism showed a lack of co-segregation with the disease locus, 
and significantly negative lod scores (Z) of less than -2.00 at theta= 
0.045 were generated (Table 5.3). These results indicate the RPI 7 locus 
can be excluded from a 4.7 cM genetic distance (using the Haldane map 
function) on either side of the PDEG gene. The other polymorphism at the 
5' end of the gene was largely uninformative in this kindred (Fig. 5.2b). 
Family RPD19 was also genotyped with the informative Al447G 
polymorphism (Fig. 5.3a and Fig. 5.3b). Negative lod scores for significant 
exclusion of the PDEG gene were also obtained for this family (Table 5.3). 
Table 5.3 Pairwise lod scores between adRP and intragenic markers within the positional candidate genes. 
Family DNA marker RECOMBINATION FRACTION (8) 
0.00 0.05 0.1 0.2 0.3 0.4 8 where Z = -2.00 
RPD8 PDEG -10.22 -1.89 -1.22 -0.58 -0.27 -0.10 0.045 
RPD19 PDEG -2.98 -0.14 0.02 0.07 0.03 -0.00 0.001 
RPD8 TIMP2 -20.27 -0.71 0.37 0.96 0.84 0.38 0.025 
RPD8 retinal -14.05 -1.64 -0.87 -0.08 0.19 0.12 -
fascin 
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Figure 5.Ja Segregation of the A1447G polymorphism in the PDEG gene in family RPD19. 
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5.3.2 Exclusion of TIMP2 
The Taql RFLP in the TIMP2 gene was genotyped in family RPD8 and a 
number of recombination events were evident between the gene and the 
adRP locus (Fig. 5.4). It is apparent that some of the adRP affected family 
members have the genotype [1/ 1], whereas others have the genotype 
[2/2], indicating that these individuals do not share a common allele. 
This suggests that the TIMP2 gene is not linked to the adRP locus in this 
family. Significantly negative two point lod scores between the disease 
locus and the TIMP2 gene were obtained, providing evidence for exclusion 
of this candidate gene (Table 5.3, page 118). Lod scores of -2.00 were 
obtained at theta= 0.025, which excludes a 2.6 cM genetic distance on 
either side of the TIMP2 gene. 
5.3.3 Exclusion of PKCA 
All three RFLPs in the PKCA gene, which had been genotyped in family 
RPD8 were uninformative in the family. For the RsaJ. and Kpnl RFLPs, all 
the family members were homozygous at these two loci. For the DraJ. 
RFLP, eight individuals were heterozygous at this locus, however, the 
marker was effectively uninformative in the family. These results may be 
due to the low level of heterozygosity reported for these intragenic 
markers (Summar et al. 1989). The lack of informativity means that no 
conclusions could be drawn as to whether this gene may be included or 
excluded as a candidate for the RPl 7 locus and further investigations 
involving this gene were therefore necessary. 
Since the intron-exon boundaries of the PKCA have yet to be established, 
the cDNA was sequenced in an adRP patient and an unaffected family 
member from family RPD8 in order to screen for pathogenic mutations. 
TIMP2 poly 
1/2 
2/2 1/1 111 I 111 111 
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Figure 5.4 Pedigree of family RPD8 il1ustrating the genotypes of the polymorphism in the TIMP2 gene. 





In total, 1727 bp of the 2245 bp PKCA cDNA was sequenced in an adRP 
affected individual but no disease-causing mutations were detected. 
During the sequencing of PKCA cDNA, a YAC/BAC contig was 
constructed for the RPl 7 critical interval, as discussed in Chapter 4. The 
YACs and BACs comprising the contig were screened for the presence of 
a PKCA EST. The lack of a PCR product of the appropriate size in any of 
the clones, except in the lane for the positive control, suggest that PKCA 
may not reside in the RPl 7 critical interval. Furthermore, according to a 
radiation hybrid map of 17q22-25.3, PKCA was shown to map between 
the microsatellite markers D 1 7S942 and D 17S807 which lie distal to the 
refined RPl 7 locus. 
5.3.4 Exclusion of retinal fascin 
The entire coding region and the putative promoter region of retinal 
fascin were screened for mutations in families RPD8 and RPD 19 by direct 
DNA sequencing. Two different intragenic single nucleotide 
polymorphisms (SNPs) in the putative promoter region and an intragenic 
SNP in exon 1 were identified. These SSCP-detectable polymorphisms 
were genotyped in the two adRP kindreds (Fig. 5.5 and Fig. 5.6) Negative 
lod scores of Z= <-2.00 were obtained for both families (Table 5.3, page 
118), thereby providing evidence for exclusion of this candidate gene. 
Moreover, DNA sequencing of the five exons of the gene in an affected 
member from each of the families did not reveal any pathogenic 
mutations, thereby corroborating the negative linkage results. 
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The search for the complete set of genes causative of retinitis pigmentosa 
consumes the efforts of numerous laboratories worldwide. Linkage 
analysis has sometimes pointed the way but the candidate gene 
approach has been responsible for many successful identifications of 
defective genes. 
However promising a candidate gene appears for a disorder, it must be 
shown to be mutated in family members affected with the condition. 
Initially, the candidate gene is examined for co-segregation with the 
disease phenotype using a closely linked or intragenic polymorphism. In 
the event that the marker co-segregates, is uninformative in the family, 
or if no neutral intragenic polymorphisms are available, the next step 
involves mutation detection methods which are numerous and vary in 
sensitivity and technical complexity. The most popular of these 
techniques are SSCP, chemical mismatch cleavage, denaturing gradient 
gel electrophoresis (DGGE), protein truncation test (PTT), cleavase 
fragment length polymorphism (CFLP) and direct sequencing of the exons 
or cDNA. Ultimately, the choice of method depends on a variety of factors 
including the size of the gene, the level of expertise for a particular 
procedure and the availability of equipment. 
The positional candidate gene approach was adopted in this study in an 
attempt to identify the RPl 7 gene. Using a variety of experimental 
techniques, evidence is provided which suggests that the candidates 
PDEG, TIMP2, PKCA and retinalfascin are not likely to be responsible for 
the adRP phenotype in the RP 17 -linked families. 
It should be noted that PDEG has not yet been implicated in a human 
hereditary retinal degeneration. Despite its key role in the rod 
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phototransduction pathway and the fact that other members of this 
pathway have been associated with retinopathies, PDEG has been 
excluded as a candidate for adRP in families RPD8 and RPD 19 (this 
study) as well as 704 unrelated patients with RP, Ushers syndrome, 
Leber's congenital amaurosis and Lawrence Moon Bardet-Biedl syndrome 
(Hahn et al. 1994). There are a number of possible explanations for this 
finding. One theory is that the protein product of PDEG may play a vital 
role in the cell and deleterious mutations could result in embryonic 
lethality. A second possibility is that of 'functional redundancy' where 
another protein may serve the same function as the product of PDEG, 
thereby ensuring that individuals with PDEG mutations do not exhibit a 
recognisable phenotype. A third scenario is that PDEG may have such a 
low mutation rate that an inherited retinal degenerative disorder due to a 
defect in this gene would occur very rarely. Mutation rates of various 
genes vary greatly and are dependent on differences in GC content and 
the timing of DNA replication (Matassi et al. 1999). 
Since the PKCA gene had not been fully characterised, an attempt was 
made to sequence the cDNA of an affected adRP family member in order 
to screen for pathogenic mutations. PKCA cDNA was isolated from 
illegitimate transcripts in immortalised lymphoblasts obtained from 
members of family RPD8. The mechanism and biological significance of 
illegitimate transcription are still obscure, but since these transcripts 
exhibit the same pathology as legitimate transcripts, they represent a 
useful tool in the study of genetic diseases (Kaplan et al. 1992a). In 
autosomal dominant disorders, the pathogenic mutation may result in a 
null allele, and therefore sequencing of the cDNA to screen for mutations 
could be misleading since only the non-mutated allele will be sequenced. 
This approach therefore has serious limitations. Although no mutations 
were detected, PKCA was subsequently shown to not reside on any of the 
mega clones spanning the RPl 7 critical interval, providing supportive 
evidence for its exclusion. 
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The photoreceptor-specific expression pattern of retinal fascin implicates 
it as a strong candidate for retinal dystrophies. This gene was excluded, 
however, from the form of RP segregating in families RPD8 and RPD 19. 
The three intragenic polymorphisms in retinal fascin identified in this 
study may facilitate linkage analysis in other families with hereditary 
retinopathies linked to chromosome 1 7 q. 
In addition to the Human Genome Project's sequencing efforts, gene 
identification methods are being developed which should generate 
additional candidates for future studies on RPl 7. Some strategies have 
evolved which specifically enrich for and isolate chromosome-specific or 
tissue-specific genes. One such technique is cDNA representational 
difference analysis (RDA) which has been employed with some success to 
isolate chromosome 17-specific cDNAs (Tajima et al. 1997). This DNA 
subtraction technique was used with a mouse-human chromosome 17 
hybrid cell line as the tester and a mouse cell line as a driver and 
identified two chromosome 17-specific clones. One is a partial cDNA 
clone containing an open reading frame (ORF) of 687 bp and the second 
clone is thought to be a full length cDNA containing a single ORF of 1206 
bp flanked by 120 and 297 bp UTRs at the 5' and 3' ends, respectively. 
Both clones are potential candidates for RPl 7 and should therefore be 
examined using Northern blot analysis to determine if they are expressed 
in the retina. 
Another successfully employed technique utilises subtractive and 
differential hybridisation to enrich for retina-specific cDNAs (Imamura et 
al. 1997). In this method, inserts in human retina cDNA libraries are 
mixed with brain cDNA inserts. The resulting subtracted retina cDNAs 
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are hybridised with cDNAs from five different human cDNA libraries 
including retina, brain and fetal liver. A novel retina-specific protein, 
designated retina-specific amine oxidase (RAO) was identified using this 
technique. RAO has an ORF of 2 187 bp and the gene (AOC2) was 
subsequently mapped by FISH to 17q21. This gene is an appealing 
. candidate for RP 1 7 and should be characterised further for investigation 
in the RPl 7-linked families. 
In conclusion, it is predicted that over 90% of future studies on human 
disease genes will employ the positional candidate gene approach due to 
its relatively high success rate (Strachan and Read 1996). For this 
reason, it is suggested that investigations of positional candidates for 
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6.1 GENERAL DISCUSSION AND FUTURE PROSPECTS 
This dissertation describes the progress made towards elucidation of the 
molecular basis of adRP in a large SA family. Genetic linkage analysis 
was used to establish linkage of the adRP phenotype in this family to a 
region on chromosome 17q22 (designated the RPI 7 locus; Bardien et al. 
1995). The disorder in a second SA adRP family was subsequently linked 
to the same locus (Bardien et al. 1997). 
I 
The identification of RPI 7 illustrates that genetic linkage analysis using 
lod scores is a powerful and efficient tool for mapping disorders in large 
families exhibiting multiple meioses. Before this method can be 
implemented, however, prior knowledge is required concerning the mode 
of inheritance, gene frequencies and the penetrance of the disorder. The 
identification of this novel locus, the eighth for adRP, further 
demonstrates the genetic heterogeneity of this group of conditions. 
Haplotype analyses suggested that the disorder in the two unrelated SA 
kindreds might be as a result of the same pathogenic mutation in the 
same gene. The two families share- a common disease-associated 
haplotype, which spans 12 cM, even though they are from ethnically 
diverse origins and reside in different geographical locations in SA. This 
finding may indicate that the families have a common ancestor and that 
they have diverged relatively recently. The eventual identification of the 
disease gene and the pathogenic mutation should resolve this debate. 
Recently, den Hollander et al. (1999) demonstrated linkage in a large 
Dutch adRP family to the RPI 7 locus. It would be interesting to compare 
the disease-associated haplotype in the Dutch family with that of the SA 
families. The Dutch group also excluded two additional candidate genes 
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for RPl 7 viz. the retina-specific amine oxidase gene (AOC2) and the cone 
transducin gamma gene (GNGT2). GNGT2 is, however, not a likely 
candidate for RP since it is expressed exclusively in cone cells. 
The identification of the disease-associated haplotype has important 
implications for pre-symptomatic members of the two kindreds. However, 
the potential advent of a predictive test based on genetic linkage using 
polymorphic markers raises ethical, moral and psychological issues. Pre-
symptomatic testing in the RPl 7-linked families will therefore only be 
implemented with appropriate genetic counselling and guidelines 
(Greenberg et al. 1996). 
RP 1 7 was refined to a 1 cM region (Bardien-Kruger et al. 1999) which is 
sufficiently small to facilitate positional cloning techniques in an attempt 
to identify the adRP gene. in this regard, a physical map comprising of 
YA Cs and BA Cs, which span the RP 1 7 region, was constructed. This 
contig consists of overlapping clones and contains both flanking 
recombinant markers thereby ensuring that the RPl 7 gene is present. 
The use of fluorescent in-situ hybridisation analysis in order to verify that 
the clones are not chimaeric would be a logical next step in this study. 
Moreover, it may prove useful to construct a cosmid or Pl contig for the 
RPl 7 region because these clones tend to retain their human DNA 
inserts, which is crucial for gene isolation experiments. However, more of 
these smaller clones are required than YACs in order to provide full 
overlapping coverage of the critical interval. 
The cDNA selection technique was utilised in an attempt to generate a 
transcription map of the RPl 7 critical interval. This approach was 
applied to one of the YACs from the RPl 7 contig with the use of a foetal 
brain cDNA library. The presence of a 23 bp contaminant was detected 
and it is essential that this sequence be screened out before further 
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analyses of the transformants can be undertaken. It would also be 
advisable to repeat the selections with a retina-specific cDNA library, 
which should generate fewer candidate genes, thereby increasing the 
chances of identifying the adRP gene. Furthermore, it would be 
appropriate to subject the other six YACs and two BACs to cDNA 
selection and other gene isolation experiments in order to identify all the 
transcription units in the region. Genes identified in this proposed 
extensive study would first need to be fully characterised in terms of 
their expression-pattern, exon-intron boundaries, promoter regions etc. 
Each of the genes would then have to be investigated in turn for evidence 
implicating them as the adRP gene. An important observation1 is that the 
cloning of genes from the RPl 7 contig would also provide candidates for 
other disorders that map to 1 7 q22. 
Four positional candidate genes residing on 17q (viz. PDEG, TIMP2, PKCA 
and retinal fascin) were excluded from being associated with the adRP 
phenotype in the RPl 7-linked families. Candidate gene screening is set to 
dominate the field of disease-gene isolation and as additional candidates 
for RPl 7 are identified it is advisable that they be investigated in the two 
SA families. Other potential candidates include the TBX2 gene which was 
shown to reside on one of the clones in the RPl 7 contigviz. YAC 961fl 
(Law et al. 1995). It is imperative that the computerised databases and 
the current literature be scrutinised on a regular basis to reveal 
additional positional candidates for study. 
An important future extension of this study would be to further· 
investigate the canine prcd locus, postulated to be the canine homologue 
of RPl 7 (Acland et al. 1998). Genetic linkage analysis facilitated the 
mapping of the prcd locus to an approximately 5 cM region between the 
TKl and GALKl genes, thereby excluding the RARA [retinoic acid 
receptor alpha gene] (Acland et al. 1998). RARA had been considered to 
be a potential candidate for RPI 7 due to its role in retinol (vitamin A) 
metabolism (Petkovich et al. 1987). 
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One of the two strategies used in the present study, positional cloning, is 
an arduous and time-consuming approach for the identification of 
disease-causing genes. This is illustrated by the fact that RPGR and RP2 
are the only two RP genes that have been isolated using this method 
(Table 6.1). The first RP gene to be identified using positional cloning was 
RPGR. This gene was mapped in 1988 to chromosome Xp2 l. 1 and cloned 
in 1996 (Musarella et al. 1988; Meindl et al. 1996). In the case of RP2, 
the gene was mapped in 1984 to Xpl 1.3 by linkage analysis with a DNA 
marker Ll.28 (Bhattacharya et al. 1984). The causative gene was isolated 
using positional cloning more than a decade later in 1998 (Schwahn et 
al. 1998). The candidate gene approach has been more successful with 
the identification of a number of RP genes including rhodopsin, PDEA 
and PDEB (Table 6.1). In this technique the DNA sequence of the 
candidate gene is examined for mutations in affected individuals, which 
can be rather labour-intensive when the genes are large and consist of 
many exons. Currently, these are the only strategies available for studies 
on RP since the primary biochemical defects in this group of disorders 
are still unknown. The conventional approach used to clone genes, 
functional cloning, requires pre-existing knowledge about the 
pathogenesis of the disorder. A systematic study of tissues from 
individuals affected with RP may lead to a consistent biochemical clue, 
thereby making this approach plausible in the future. 
Table 6.1 Strategies used for identification of the genes implicated in retinitis pigmentosa. 
l)isease-:tait1ing . ·.Dis))rder '.$trategy:·usid ; .. ,,,,. i.· <}, ,.,)i R~(erence . X.' 
·g~ne !.\·f '~<> ' 
;{"··, ,. , .. 
"·; 
• ;~ •• ' > 
/< .· .; .. ; :.::4(; '/ . i ., ;)i• /) •· .. . , . .• ;; ... :·' ". , . 
Rhodopsin adRP Linkage + candidate gene approach Dryja et al. 1990 
Peripherin/RDS adRP Linkage + candidate gene approach Farrar et al. 1991 
PDEB arRP Candidate gene approach McLaughlin et al. 1993 
ROMl Digenic RP Candidate gene approach Kajiwara et al. 1994 
PDEA arRP Candidate gene approach Huang et al. 1995 
CNGC arRP Candidate gene approach Dryja et al. 1995 
Myosin VIIA Usher syndrome type lB Linkage + candidate gene approach Weil et al. 1995 
RPGR xlRP Positional cloning Meindl et al. 1996 
RLBPl arRP Linkage + candidate gene approach Maw et al. 1997 
RP2 xlRP Positional cloning Schwahn et al. 1998 




6.2 MODELS FOR PATHOGENESIS OF RP 
6.2.1 Apoptosis 
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Molecular genetic investigations such as the present study are important 
to elucidate the molecular patho-physiology of inherited retinal disorders. 
There are currently numerous hypotheses regarding the pathogenic 
mechanism responsible for the death of rod and cone cells in RP. One 
theory implicates apoptosis, a form of programmed cell death, for the loss 
of photoreceptors (Lolley et al. 1994; Gregory and Bird 1995). In 
apoptosis, genetic switches in the cell initiate the turning off of normal 
cellular activity, resulting in DNA fragmentation, condensation of nuclei 
and cell death. This process is a genetically encoded potential' of all cells 
and it plays an essential part in embryonic development. Apoptosis has 
been shown to be the cause of photoreceptor cell death in mouse models 
for RP involving mutations in three different genes viz. rhodopsin, 
peripherin/ rds and the ~ subunit of phosphodiesterase (Chang et al. 
1993). In addition, in the Royal College of Surgeons (RCS) rat model, 
where expression of the primary genetic defect is in the RPE, the 
biochemical hallmarks of apoptosis were observed in the photoreceptor 
cells (Mullen and Lavail 1976). Cell death in some forms of retinal 
degeneration may therefore not be a direct consequence of the intrinsic 
genetic defect but may represent a reaction to a change in the metabolic 
environment of the tissue. It would be interesting to establish whether 
apoptosis is also responsible for rod and·cone cell death in the RPl 7-
linked families. 
6.2.2 Constant equivalent light model 
Another proposed pathogenic mechanism is the 'constant equivalent 
light' model (Lisman and Fain 1995). Prolonged exposure of the retina to 
constant illumination is known to produce photoreceptor cell death in 
rodents (Noell et al. 1966). Some of the molecular defects associated with 
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RP are thought to produce electrical signals 'equivalent' to those 
produced by real light and they thereby trigger degeneration by the same 
mechanism. Strong support for this hypothesis are the observations that 
mutations in both the cGMP-gated ion channel gene and th~ 
chromophore-opsin attachment site (codon 296) of rhodopsin are 
causative of RP (Dryja et al. 1995; Lisman and Fain 1995). These 
mutations are thought to lead to over-stimulation of the 
phototransduction cascade, a situation which is similar to constant light 
exposure. 
6.3 CONCLUSION 
Once the genetic defect responsible for RPl 7 has been identified, a future 
extension of the research would be to produce an animal model to 
determine the exact mechanism of cell death. Rodent models of RP have 
a rapid rate of photoreceptor cell degeneration, which makes a study of 
the protracted phase of cone degeneration not feasible. Larger animal 
models such as the rhodopsin transgenic pig (Petters et al. 1997) have a 
slower rate of cell death and the size and structure of the porcine eye is 
roughly similar to that of humans. These features make this species 
more suitable for the study of human retinal degenerative disorders. 
In the long term, the question of treatment for the RPl 7-linked families 
could be addressed, once an animal model and the appropriate gene-
therapy vectors have been established. The work presented in this 
dissertation provides the basis for future research, which will have the 
potential to ultimately contribute towards development of effective 
therapy for this currently untreatable disorder. 
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The mapping of RP 1 7 and other RP loci in our laboratory provided the 
impetus for the establishment of a registry for retinal degenerative 
disorders. In this regard, the genealogical and ophthalmological details 
on every individual and family member are entered into our 
computerised database. This bank of information has the potential to be 
extremely valuable for the future management and treatment of affected 
individuals and their families, and the Department is now recognised as 
a national referral centre for retinal degenerative disorders in South 
Africa. 
In conclusion, the main findings resulting from this investigation are: 
+ assignment of the disease gene to a 1 cM region on 17q22 
+ linkage of a second SA family 
+ establishment of a potential predictive test for the two adRP families 
+ exclusion of four candidate genes 
+ construction of a contig which is a valuable resource for the eventual 
cloning of the adRP gene as well as other genes. 
With the explosion of sequence and structural information available to 
researchers, the burgeoning field of bioinformatics, or more properly, 
computational biology, is playing an increasingly important role in the 
study of fundamental biomedical problems. The challenge facing 
scientists, especially in the light of the vast amount of data being 
generated by the Human Genome Project, will be to use the publicly-
funded electronic databases [such as the Genome Database (GDB) and 
the National Center of Biotechnology Information (NCBI)] and computer 
software to help solve complex biological problems. With the tools that 
are available for this new age of sequence-based biology, the coming 
years should prove very exciting and fruitful for all projects involving the 
search for human disease genes such as RP 17. 
APPENDIX A, B & C 
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APPENDIX A 
A.1 Department of Human Genetics request form for biological specimens. 
REQUEST FOR MOLECULAR STUDIES (DNA) 
- Molteular Laboratory 
Department of Buman Genetics 
1st Floor, Anatomy Building 
UCT Medical School, Observatory, 792S 
Td: (021) 406 6425 Fax: (021) 477703 
Pl= fill in all the information llf/U~d 
Blood should be drawn io 3 plastic EDTA tubes 
(Purple top) +I- 10 ml each using a yellow barrd. 
Each tube should be iovened to mis. 
Keep blood lo fridge at 4°C until able to sud to 
laboratory. 
Please DO NOT send specimens on ice or frozen. 
Samame: First Name(s): _____________________ _ 
New Family: Va O No D (If oo, please fill iD family ruuK) Family asme: ________________ _ 
Medic:al Aid: Mediul A.id No.: ---------
Sa: MO FD DateofBirtb: Year. ___ Mootb: Day: _____ _ 
No. of Children:---------
£tbDic Ori&io: BlackO lndianO Mi:&ed ancestry D 
Coatact Address: ________________ _ 
Rderrioc Doctor/Sister.-----------------
Hospital or Address:---------------








Affected 0 At Risk 0 Carrier 0 Spouse 0 Query D Unaffected 0 
Becker Muscular Dystropy 0 




Ducbenne Muscalar Dys. 
Haemophilia A 
Splnoc:erd>dlar Atuia 
0 Colonic Carcinoma 0 
0 Baatingtoo Diseue 0 
0 Wurdenburc Synd..- 0 
Additioul disorders (apparent or previously treated: -----------------------
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B. l DNA isolation from lymphocytes 
B.2 RNA isolation from transformed lymphoblasts 
B.3 DNA oligonucleotides 
B .4 Southern blot analysis 
B.5 Single strand conformation polymorphism analysis (SSCP) 
B.6 DNA sequencing 
B.7 YAC agarose plugs 
B.8 Pulsed-field gel electrophoresis (PFGE) 
B.9 cDNA selection 
B.1 DNA ISOLATION FROM LYMPHOCYTES 
DNA was isolated using a modified version of the Genomix kit (Talent, Italy) as 
described below: 
• 10 ml of frozen venous blood was thawed at 37°C and added to 2 ml of Blood 
Washing Solution (BWS). After centrifugation at 7000 rpm for 15 min at room 
temperature, the pellet was resuspended in 5 ml of BWS. The centrifugation step 
was repeated. 




• After addition of 4 ml of Lysing solution, the mixture was incubated at 68°C for 7 
min. 
• The lysate was transferred to a 14 ml gel barrier t:ube and chloroform was added 
with vigorous mixing in order to mix the two phases. The phases were separated by 
centrifugation at 5 000 rpm at 4°C for 30 min. The upper aqueous phase was 
poured into a 30 ml Corex glass tube, which had previously been treated with 
diethyl pyrocarbonate. 
• 7 ml of Precipitating solution was added and mixed gently by slow inversion until a 
filamentous DNA precipitate was visible. 
• After removal of the liquid phase, the precipitate was resuspended in 4 ml of Ionic 
Exchange solution and left 0/N at RT. 
• The following day, 8 ml of ethanol was added and the DNA precipitate was washed 
twice in 5 ml of 70% Ethanol and transferred to a 1.5 µl Eppendorf tube. Following 
centrifugation at 13 000 rpm for 1 min, all the supernatant was removed and the 
DNA pellet was air-dried. Finally, the DNA was resuspended in 200 µl of water 
and the concentration was calculated from the absorbance at 260 nm (1 OD unit = 
50 µg/ml). 
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B.2 RNA ISOLATION FROM TRANSFORMED LYMPHOBLASTS 
Where appropriate all the reagents and equipment used in this protocol were treated 
with diethyl pyrocarbonate (DEPC) prior to use. 
• 10 ml of EBY-transformed lymphoblasts were centrifuged in a polypropylene tube 
at 2000 rpm for 5 min and the pellet was washed in 1 ml of phosphate buffered 
saline (PBS). 
• The following solutions were added sequentially, with vortexing after each addition: 
Solution D 1 ml 
2M Na Acetate (pH 4) 0.1 ml 
water saturated phenol 
chloroform:isoamyl alcohol (49: 1) 
1 ml 
0.2ml 
• The reaction was incubated on ice for 15 min and then centrifuged at 10 000 g for 
20 min at 4°C. 
• The RNA is in the top aqueous phase and 750 µl of this layer was removed to a 
microfuge tube, 750 µl of isopropanol was added and the RNA was precipitated 
0/N at -20°C. 
• The following day, the RNA was pelleted by centrifugation at 10 000 g for 10 min, 
washed with 70% ethanol, airdried and finally resuspended in 20-50 µl distilled 
water. 
i) First strand cDNA synthesis: 
2.5 µg of RNA was reverse transcribed with AMV reverse transcriptase (Promega, 
USA) using oligo dT as a primer. The reaction was incubated for 1 hour at 42°C and in 
order to yield sufficient cDNA, 3 cycles of linear amplification of the RNA were 
performed. 
ii) The reverse transcribed RNA was PCR amplified using the appropriate primers and 
the product was directly sequenced. 
B.3 DNA OLIGONUCLEOTIDES 
All DNA oligonucleotides used in this study as primers for PCR or as probes in 
Southern blot analysis were obtained from the following sources: 
+ Research Genetics (USA) 
+ GIBCO/BRL (USA) 
+ Department of Biochemistry at UCT 
+ overseas collaborators 
B.4 SOUTHERN BLOT ANALYSIS 
7 .5 µg of genomic DNA was digested to completion with the appropriate restriction 
enzyme and separated by electrophoresis on 0.6% agarose gels 0/N at 45 W. 
B.4.1 Transfer to nylon membranes 
The DNA was transferred 0/N from the gel to Hybond N+ membranes (Amersham, 
UK) using 0.4 M NaOH. 
B.4.2 Hybridisation 
[a32P]dCTP- labelled probes were prepared by one of two methods: 
(i) The Multiprime DNA labelling system (Amersham, UK) 
(ii) The Rediprime DNA labelling system (Amersham, UK) 
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· These protocols were performed according to the manufacturers' instructions. The 
blots were first pre-blocked in a hybridisation solution containing Salmon Sperm 
(Appendix C) and then hybridised to the denatured probes 0/N at 65°C. The following 
day, the membranes were washed over three stages: 
• 3X SSC at RT for 10 min 
• 3X SSC/ 01 % SDS at 65°C for 30 min 
• 0.6X SSC/ 0.3 % SDS at 65°C for 30 min 
B.4.3 Autoradiography 
Autoradiographs were obtained by exposure of the membrane to X-ray film (Agfa 
Curix, Germany) 0/N at -70°C. 
B.5 SINGLE STRAND CONFORMATION POLYMORPHISM 
ANALYSIS {SSCP} 
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The exonic sequences of genes were PCR amplified in 200-300 bp fragments. An equal 
volume of SSCP loading dye was added and the samples were loaded on MDE gels: 
B.5.1 Gel matrix 
The gels consisted of 0.5X MDE matrix (FMC BioProducts, USA), 0.6X TBE and 
either with or without 10% glycerol. The glass plates used for the gels were 380 cm 
long and 300 cm wide; and the combs and spaces were 0.375 mm thick. 
B.5.2 Electrophoresis conditions 
PCR products were denatured at 95°C for 5 min, chilled on ice for 10 min and loaded 
on the MDE gels. The gels were electrophoresed 0/N at 2 to 6 W (depending on 
fragment size) on an in-house gel tank system with 0.6X TBE running buffer._ 
B.5.3 Silver staining 
In order to visualise the bands the gels were stained over three stages in: 
• 0.1 % Silver Nitrate for 20 min 
• 1.5% NaOH/ 0.15% formaldehyde for 10 min 
• 0.75% Sodium Carbonate for 10 min 
The gels were washed in distilled water between each solution. 
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B.6 DNA SEQUENCING 
Direct DNA sequencing was performed by one of three different methods: 
• The Sequenase II sequencing Kit (Amersham, USA) 
• The SequiTherm EXCEL II DNA Sequencing Kit (Epicentre Technologies, USA) 
• ABI PRISM Dye Primer Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, 
USA). 
In each case, the protocols were followed according to the manufacturer's instructions. 
In the first two methods, [a.32P]dCTP was incorporated into the sequencing reactions 
which were subsequently electrophoresed on 6% denaturing polyacrylamide gels at 
60 W in lX TBE. After the run, the gels were dried at 80°C and autoradiographed at 
I 
-70°C. For the A~I Kit, the sequencing reactions were separated by automated 
capillary electrophoresis and analysed by an ABI PRISM Genetic Analyser (Perkin 
Elmer, USA). 
B. 7 Y AC AGAROSE PLUGS 
• 50 ml cultures were grown for 2 days in casein media containing Ampicillen (100 
µg/ml). 
• The cells were pelleted at 3000 rpm for 5 min, washed with distilled water and 
recentrifuged. 
• The pellet was resuspended in 1 ml SCE and 7 µ1 beta-mercaptoethanol (BME) and 
incubated at 50°C. 
• 3 ml of 2 % InCert agarose (FMC BioProducts, USA) containing 0.01 g/ml yeast 
lytic enzyme (ICN) in SCE was prepared and added to the cell mixture at 50°C. 
• This mixture was quickly dispensed into the slots of a plug mould (Biorad, USA) 
and allowed to set at 4 °C for 25 min. 
• The plugs were washed in: 
(i) 20 ml SCE, 140 µ1 BME and 10 mg/ml YLE at 37°C for 5 hrs. 
(ii) 10 ml lysis solution and 1 mg/ml proteinase K at 50°C 0/N. 
• The following day, the plugs were washed 3X in TE with gentle shaking at room 
temperature for 15min. 
• The plugs were stored in 0.05 M EDTA at 4°C and were stable for up to a year 
under these conditions. 
B.8 PULSED-FIELD GEL ELECTROPHORESIS (PFGE) 
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200 ml of 1 % Pulsed-field Certified agarose (Biorad, USA) gel was prepared in 0.5X 
TBE. Once the gel had set, the YAC agarose plugs were loaded into the wells and 
sealed in using 1 % Pulsed-field Certified agarose. After 20 min, the gel was placed in a 
I 
BIORAD CHEF DR II Mapper System, allowed to cool to 14°C for 30 min and run at 
the appropriate conditions in 0.5X TBE. Upon completion of the run, the gel was 
stained for 30 min in 400 ml of 0.5X TBE containing 20 µI of 1 % Ethidium bromide. 
The gel was then destained at 4°C 0/N and the following day, the gel was 
photographed under UV. 
B.9 cDNA SELECTION 
• 200 ng of YAC DNA was biotinylated using a Nick Translation Kit (Boehringer 
Mannheim, Germany) and biotin-16-2'-deoxyuridine-5'-triphosphate according to 
the manufacturer's instructions. 
• 10 ng of the foetal brain cDNA library was amplified in ten identical 25 µI PCR 
reactions which were then pooled and eluted through a Sephadex G-50 spin column. 
• Following elution, the starting cDNA was ethanol precipitated and resuspended in 
TE to a final volume of 1 µg/ µI. 
• The cDNA was blocked with COT-1 DNA, AB1380 DNA and pBluescript vector in 
a total volume of 10 µI. The reaction was overlaid with mineral oil and the DNA 
was denatured at 95°C for 5 min. After addition of 10 µI of 2X hybridisation 
buffer, the reaction was incubated at 65°C for 4 hrs. 
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• 5 µl of biotinylated Y AC DNA was denatured at 95°C for 5 min, mixed with 5 µ1 
of 2X hybridisation solution and immediately added to the blocked cDNA. The 
hybridisation was allowed to proceed at 65°C for at least 54 hrs. 
• After hybridisation, the biotinylated YAC DNA with the hybridised cDNAs was 
captured on streptavidin-coated paramagnetic Dynabeads (DYNAL, Norway). 
• The hybrids were washed: 
i) 2X in 1 ml of wash solution 1 (IX SSC/ 0.1 % SDS) for 15 min at RT 
ii) 3X in 1 ml of wash solution 2 (0. lX SSC/ 0.1 % SDS) for 15 min at 65°C. 
At each washing cycle, the beads were removed from solution with a magnetic 
particle separator. 
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• After the final wash, the beads were resuspended in 50 µl of freshly-prepared 0.1 M 
NaOH at RT for 20 min and concentrated in a magnetic particle separator for 1 
min. 
• The supernatant containing the eluted cDNA was transferred to a 1.5 µl eppendorf 
tube, neutralised with 50 µl of 1 M Tris-HCl (pH 7 .5) and passed through a 
Sephadex G-50 spin column. This eluted material constitutes the primary selected 
cDNAs. 
• These cDNAs were PCR amplified and passed through a second round of selection 
in order to generate the secondary selected cDNAs. 
• The secondary selected cDNAs were then cloned and analysed. 
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APPENDIXC 
Media, Buffers and Solutions: 
C.1 casein media 
C.2 TBE (IX) 
C.3 formamide loading dye 
C.4 6 % denaturing polyacrylamide gels 
C.5 SSCP loading dye 
C.6 hybridisation solution for Southern blots 
C.7 cD NA selection buffers 
C.8 SCE 
C. 9 lysis solution 
C.10 Solution D 
C .1 Casein media 
For IL: 
6.7 g yeast nitrogen base without amino acids 
10 g casamino acids 
20 g Dextrose 
0. 07 g Adenine (hemisulphate) 
Add 15g Bacto-Agar for plates. 
C.2 TBE (lX) 
0.089 M Tris 
0.089 M Boric acid 
0.002 M EDTA (pH 8.0) 
C .3 Formamide loading dye 
80 % formamide 
10 mM EDTA (pH 8.0) 
0.1 % xylene cyanol 
0 .1 % bromophenol blue 
C .4 6% denaturing polyacrylamide gels 
5.7% acrylamide 
0.3 % bis-acylamide 
7.65 M urea 
IXTBE 
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C .5 SSCP loadin2 dye 
95 % formamide 
20 mM EDTA (pH 8.0) 
lOmMNaOH 
0.02 % xylene cyanol 
0.02 % bromophenol blue 
C.6 Hybridisation solution for Southern blots 
1 M NaCl 
1% SDS 
5 % Dextran sulphate 
10% PEG 6000 
100 µg per ml denatured Salmon Sperm 
C.7 cDNA selection buffers 
Binding buffer 
10 mM Tris (pH 7.5) 
1 mM EDTA 
1 M NaCl 
2X hybridisation solution 
1.5 M NaCl 
40 mM Sodium phosphate (pH 7 .2) 
10 mM EDTA (pH 8.0) 




1 M sorbitol 
0.01 M sodium citrate 
0.06 M EDTA (pH 7.0) 
C.9 Lysis solution 
10 mM Tris 
1 % n-Lauroyl sarcosine 
0.45 M EDTA (pH 7.8) 
C .10 Solution D 
Stock solution: 





0.75 M Na Citrate (pH 7) 3.5 ml 
10% Sarkosyl 5.3 ml 
•• •M• ..... ~ .... ••'•, ••• :.:.·.- ... _:.:;•,; .. ;, .. :.·,;.~•.!~~.,;:;!~ •• · 
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